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Preface
Chapters 2-5 have each been written as separate manuscripts. Given
this, there may be some repetition of presented material, particularly
in the methodology of experiments, between Chapters 2 and 3 as
well as between Chapters 4 and 5.
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ABSTRACT
Lower extremity assistive robotic devices, such as exoskeletons and prostheses, have the
potential to improve mobility for millions of individuals, both healthy and disabled. These
devices are designed to work in conjunction with the user to enhance or replace lost func-
tionality of a limb. Given the large variability in walking dynamics from person to person,
it is still an open research question of how to optimally control such devices to maximize
their benefit for each individual user. In this context, it is becoming more and more evident
that there exists no “one size fits all” solution, but that each device needs to be tuned on a
subject-specific basis to best account for each user’s unique gait characteristics. However,
the controllers that run in the background of these devices to dictate when and what type
of actuation to deliver often have up to a hundred different parameters that can be tuned
on a subject-specific basis. To hand tune each parameter can be an extremely tedious and
time consuming process. Additionally, current tuning practices often rely on subjective
measures to inform the fitting process.
To address the current obstacles associated with device control and tuning, I have de-
veloped novel tools that overcome some of these issues through the design of control archi-
tectures that autonomously adapt to the user based upon real-time physiological measures.
This approach frames the tuning process of a device as a real-time optimization and allows
for the device to co-adapt with the wearer during use. As an outcome of these approaches,
I have been able to investigate what qualities of a device controller are beneficial to users
through the analysis of whole body kinematics, dynamics, and energetics.
The framework of my research has been broken down into four major projects. First,
I investigated how current standards of processing and analyzing physiological measures
xi
could be improved upon. Specifically, I focused on how to analyze non-steady-state mea-
sures of metabolic work rate in real time and how the noise content of theses measures can
inform confidence analyses. Second, I applied the techniques I developed for analyzing
non-steady-state measures of metabolic work rate to conduct a real-time optimization of
powered bilateral ankle exoskeletons. For this study I employed a gradient descent opti-
mization to tune and optimize an actuation timing parameter of these simple exoskeletons
on a subject-specific basis. Third, I investigated how users may use an adaptive controller
where they had a more direct impact on the adaptation via their own muscle recruitment.
In this study, I designed and tested an adaptive gain proportional myoelectric controller
with healthy subjects walking in bilateral ankle exoskeletons. Through this work I showed
that subjects adapted to using increased levels of total ankle power compared to unpowered
walking in the devices. As a result, subjects decreased power at their hip and were able
to achieve large decreases in their metabolic work rate compared to unpowered walking.
Fourth, I compared how subjects may use a controller driven by neural signals differently
than one driven by mechanically intrinsic signals. The results of this project suggest that
control based on neural signals may be better suited for therapeutic rehabilitation than con-
trol based on mechanically intrinsic signals. Together, these four projects have drastically
improved upon subject-specific control of assistive devices in both a research and clinical
setting.
xii
CHAPTER 1
The Control of Assistive Robotic Devices
1.1 Motivation and Identifying a Need for Research
There is an ever growing population of people that struggle with daily locomotion due to
neurological impairment or amputation [57,99]. These disabilities may be a result of stroke,
trauma, diabetes, spinal cord injury, or neurological disease and degradation. Regardless
of the cause of debilitation, much of this population is putting forth more effort to move
then their healthy counterparts. For example, people with stroke (hemiplegia) exhibit large
asymmetries in their gait due to resulting impairments, such as drop foot, that can result
in a 5%-29% increase in their metabolic work rate during walking compared to healthy
controls [149]. Additionally, people with transtibial amputation lack the ability to supply
any positive work at the ankle resulting in a 10%-30% increase in their metabolic work rate
during walking as compared to healthy individuals [72, 137]. These disabled populations
could greatly benefit from assistive robotic devices, such as exoskeletons or prosthesis, to
either aid in their rehabilitation or replace lost functionality [26, 35].
Lower extremity assistive robotic devices are mechanical structures designed to be worn
by and work in conjunction with the user during locomotion. In doing so, these devices
perform positive work on the user to aid with walking or running. The success of such
devices is commonly evaluated using a number of physiological measurements such as gait
kinematics, joint dynamics, gait symmetry, muscle activity, and/or energetic consumption
[147]. Theoretically, the synergy between the device and the user has the potential to make
it easier for the user to move [78,132]. As such, we would expect a well designed device to
offload some of the energy needed from the user to ambulate. This offloading could result in
a reduction in the user’s metabolic work rate as an outcome of other biomechanical changes.
Nonetheless, it is still an open research question as to how to best supply assistance to the
user and what the biomechanical implications are of using these devices.
Early work in the field of rehabilitation robotics proved that assistive devices could pos-
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itively affect users’ locomotion [7, 32, 66, 116]; however, there were many failed attempts
made along the way [62,134,136,138]. These early studies have illustrated just how sensi-
tive the performance outcomes of a device are to the overall design. From a hardware per-
spective, the device weight or kinematic constraints imposed on the user can result in large
increases in a wearer’s metabolic work rate making it more difficult to move [21,109,131].
However, hardware is not the only aspect to consider in device design. Software can also
play a big role in performance outcomes. From a software perspective, if a device is not
controlled properly it can also result in large increases in a wearer’s metabolic work rate as
the device can potentially be fighting movement rather than aiding in it [77].
Recent work has shown that users’ physiological measures are highly sensitive to the
software tuning of a device’s control parameters. Control parameters are scalar values in
the control architecture, such as gains or thresholds, that dictate aspects of a device’s actu-
ation. These control parameters may correspond to actuation characteristics such as virtual
impedance, peak power output, or timing. Differences in such actuation characteristics can
have large effects on the biomechanics and energetics of the wearer. Malcolm et al. was
one of the first to show that systematically varying a control parameter can have a drastic
effect on a physiological measure, in this case metabolic work rate [101]. In their work,
Malcolm et al. varied the actuation onset timing of bilateral ankle exoskeletons that aided
with push off during the stance phase of walking. One could imagine that if the timing of
such actuation occurred too early in the stance phase, the actuation may do negative work
on the body as it tries to push the center of mass backwards. If the timing were to occur
too late in the stance phase, the actuation may do negligible positive work on the body.
The results of this parameter study showed that there existed an optimal timing that re-
sulted in the largest reduction in metabolic work rate. Similar studies have been conducted
where other parameters that dictate timing, toque, work, power, or virtual stiffness of a
device’s actuation have been varied to identify what may be the best tuning for different
controllers [28, 33, 37, 49, 77]. These studies primarily serve as evaluations of different de-
vices and as basic science studies to investigate how the human body adapts and responds
to different forms of assistance. To tune a device for real-world use by this type of brute
force parameter exploration would be extremely time consuming and impractical for mul-
tidimensional parameter spaces.
The aforementioned studies have presented resulting favorable parameter configura-
tions as global best solutions across subjects; however, more recent research has shown
that there is a large benefit to subject-specific parameter configurations. For example, Que-
sada et al. conducted a parameter study where they varied the amount of push off work done
by a powered prosthetic for six different amputee subjects [110]. Their results show that
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when considering metabolic work rate on a subject-by-subject basis, the optimal amount
of push off work varied drastically for each user. It seems logical that each individual
user may need unique parameter configurations given that there exists large amounts of
anthropometric and gait variability from person-to-person which would result in each indi-
vidual using the device somewhat differently [58,142]. The idea of subject-specific tunings
of device parameters is not a new concept; however, it is only recently being objectively
quantified.
The notion of a subject-specific tuning of device parameters has long been acknowl-
edged during clinical fittings of these devices; yet, the tuning process in a clinic is quite
subjective. For a device tuning, a clinician will often custom tune parameters for an indi-
vidual patient while the patient walks around the clinic. During these walking bouts the
clinician is using visual cues of the patient’s gait, verbal feedback from the patient, and
some measured feedback from sensors on the device in order to identify what they think is
the best parameter configuration [55, 114, 124]. Tuning these devices is a lengthy process
that is largely heuristic and can vary from clinician to clinician due to the subjective nature
of the tuning process. Given that these devices can have dozens of control parameters to
tune, it becomes exceedingly complicated and time consuming to fit devices on a subject-
specific basis [14, 93]. This high dimensional parameter space also makes for a systematic
evaluation of each parameter setting nearly impossible. Additionally, users will adapt their
gait over time to the added assistance provided by the device [52, 59, 116]. This user adap-
tation makes the ideal parameter configuration a moving target since it changes over time
as the wearer better learns to use the device.
The Challenge: Currently there is a large gap between how assistive devices are tuned
in a clinic setting and how they are evaluated in a research setting. Clinical tunings are re-
lying on a heuristic and subjective approach to tuning while in a research setting these same
types of devices are evaluated using objective measures. Both of these means of tuning and
evaluation are highly iterative processes which can be extremely time consuming and often
inaccurate over long periods of time due to user adaptations. There is a clear need for more
rigorous and objective tuning methods that can also account for the adaptation of the user.
The Solution: Device tunings need to be objectively informed in the same manner
in which their success is evaluated. Previous research that suggest optimal tunings based
upon evaluation metrics have framed the tuning process as a form of parameter study;
however, this framework breaks down as the parameter space grows in dimensionality.
Alternatively, our research group has begun to frame this tuning problem in the context
of an optimization problem. By framing the tuning of such devices in this manner, the
mathematical relationship between a physiological measure and device parameter settings
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can be thought of as a type of cost landscape. These cost landscapes are unique to each
individual user due to distinct gait characteristics and can potentially change over time
with user adaptations. In the work presented here, I am proposing to automate the tuning
process such that control parameters are optimized in real-time based upon physiological
measures of the user. This gives rise to a future realm of assistive device control where the
controllers themselves autonomously adapt to individual users as users adapt to the devices
themselves.
This solution of online adaptation brings the human body into the iterative tuning and
evaluation loop and allows for a controller design to be based upon objective physiological
measurements taken directly from the user during use. In doing so, a device can be op-
timally tuned for any user across a number of tasks that the wearer encounters on a daily
basis. This ‘Body-in-the-Loop’ approach to tuning and optimizing device control allows
for a subject-specific fit of devices and allows for the adaptation of control to individual
users and scenarios.
1.2 State of the Art
In the following subsections I have introduced the background to a few select topics and
discussed some of the current research revolving around each. A more in depth background
on some of these topics are presented in the introductory sections of subsequent chapters.
Assistive Robotic Devices
There are a wide variety of lower extremity assistive robotic devices used in both a research
and clinical environment [140, 147]. These devices often rely on electromechanical actua-
tion to supply positive work to the wearer during motion. In the area of prostheses, there
are devices targeted toward transtibial (below the knee) amputees [6,11,74,123] as well as
devices targeted toward transfemorial (above the knee) amputees [56, 93, 112, 153]. In the
area of exoskeletons, there are devices that target assisting at the ankle [106], knee [122],
or hip [120] as well as any combination of the three [82, 111]. Additionally, there are
a host of many other devices and advancements that would be too numerous to describe
here [130, 146].
For the purposes of this dissertation I would like to emphasize that regardless of the
assistive device or its applications, all assistive robotic devices rely on an underlying control
architecture that determines when and how much power to supply to the user. In each of
these control architectures there are a number of different control parameters that physically
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shape the actuation that the user receives. Each of these parameters must be tuned for each
individual user. Although in the subsequent chapters of this dissertation I will be using
ankle exoskeletons as a testing platform to experimentally validate developed methods, the
presented techniques could be applied to any assistive robotic device as all require control
parameters to be tuned.
Measures of Metabolic Work Rate
Control parameters of assistive robotic devices can have a large influence on a number of
physiological outcome measures [28,37,101,102,110,138]. In order to operate in an opti-
mal way, these control parameters must be tuned on a subject-specific basis and these phys-
iological measures are used to inform these tunings. Most commonly, metabolic work rate
is the physiological measure used in a research setting to evaluate device performance and
identify optimal tuning parameters. Our field’s current standard for identifying the optimal
parameter configuration of a device is to measure user’s metabolic work rate to estimate the
user’s metabolic cost landscape. From this landscape, the optimal parameter configuration
is simply identified as the parameter configuration that minimizes the metabolic work rate.
Estimating a metabolic cost landscape is currently done by measuring users’ respira-
tory gas exchange during a brute force parameter exploration. To this end, users walk in
a device with a given parameter configuration until measured metabolic work rate reaches
a steady state. This can take multiple minutes due to inherent sensor dynamics associated
with respiratory measurements [139]. These dynamics are the result of a time delay be-
tween instantaneous energetic demand by the body and oxygen consumption measured at
the mouth. Once a steady state is reached, a few minutes of metabolic data are collected for
analysis. Such long data collections are required since measurements of oxygen uptake and
carbon dioxide output are inherently noisy, having a signal to noise ratio of approximately
4, and are sparsely sampled, having a sample rate of approximately 0.32 Hz [18, 91, 139].
Researchers repeat this collection process for each parameter configuration across the pa-
rameter space of interest, average the steady-state breath measurements, and fit a curve to
these averaged data points. This curve describes the subjects’ metabolic cost landscape.
This type of brute force parameter exploration used to identify a metabolic cost land-
scape can be quite time consuming. Unfortunately, most of this time is spent waiting for
measures of metabolic work rate to reach a steady state. Research by Selinger et al. has
targeted this pitfall by developing a simple first order model for the metabolic system [118].
In doing so, Selinger et al. has developed a means of estimating the instantaneous ener-
getic demand of the body from non-steady-state measures of metabolic work rate. Previous
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work done by our research group in collaboration with Selinger et al. has built upon this
work and shown how such techniques could be used to rapidly identify a metabolic cost
landscape [43]. Further background on this topic and an extension of this work is presented
in Chapter 2.
Parameter Studies
The standard protocol of conducting parameter studies to identify a cost landscape of a
device is deep rooted within the field of experimental biomechanics. A wide variety of
experimental biomechanics studies aim to estimate metabolic cost landscapes as a func-
tion of biomechanical manipulations. For example, studies have looked at the effects of
walking speed, walking incline, step frequency, step width, or step height on metabolic
work rate [39, 40, 63, 104, 133, 145, 150]. These types of studies are analogous to evalu-
ating and tuning the parameters on an assistive robotic device in that the biomechanical
manipulations being enforced can be thought of as the parameters of interest. However,
these biomechanics studies are specifically looking to characterize the metabolic cost land-
scape and not necessarily identify optimal gait parameter configurations to implement for
every-day locomotion. Given that there is no need for optimal biomechanical manipulation
parameters to be identified in real time, there is no major draw back to having long time
requirements for identifying the the cost landscape.
As assistive devices are becoming more complex and require multiple parameters to
tune, these brute force mapping protocols are becoming inefficient and impractical. The
time required to experimentally map a cost landscape grows exponentially with parameter
dimensionality. Galle et al. has presented work where a two dimensional space was ex-
plored using this parameter study type of methodology and the study required subjects to
walk in 12 different powered conditions for a total walking time of 48 minutes [49]. This
time requirement is within the realm of feasible walking time before fatigue sets in; how-
ever, given that more complex devices, such as the BiOM [14] or the Vanderbilt Leg [93],
have anywhere from 11 to 140 tuning parameters, these types of studies become impossible
to conduct. As such, the realm of tuning assistive robotic devices needs to begin to move
away from this type of brute force parameter exploration.
Current Tuning Practices for Complex Controllers
As discussed in the introduction to this chapter, tuning device controllers is a highly itera-
tive and subjective process. Take for example the tuning process described by Rouse et al.
for a powered knee posthesis [114]. Rouse et al. described the tuning process to consist of
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iterative walking bouts where tuning parameters were selected based upon three different
criteria:
1. A comparison of kinematic and kinetic profiles to those observed from standardized
biological datasets
2. Clinical input from a prosthetist
3. The level of comfort of the patient
In conducting this tuning, participants were asked to walk for approximately one minute
with the device powered in a given parameter configuration. After that walking bout, pa-
rameters were changed based upon the criteria above and then participants walked with the
device again. This process was repeated for 6-8 iterations per participant before the device
was configured in an acceptable tuning. The process described by Rouse et al. was a rel-
atively fast tuning process despite having 15 different parameters to tune; however, some
devices can have upwards of 100 parameters to consider.
One method for speeding up the tuning of a device with a very large number of param-
eters is to project the parameter space into a smaller dimensional space for tuning as de-
scribed by Simon et al. [124]. In this work, Simon et al. began by describing the challenges
associated with tuning parameter configurations for a powered knee and ankle prosthesis
for transfemoral amputees, specifically the Vanderbuilt Leg [127]. This prosthesis used an
impedance based controller for both the ankle and knee actuation with 5 different ambu-
lation modes (level-ground walking, ramp ascent/descent, and stair ascent/descent) where
each ambulation mode was broken into four separate finite states. Given this control break
down, the Vanderbilt Leg had a possible 140 control parameters to tune on a subject-specific
basis. Simon et al. developed a means to lower the dimensionality of this tuning space by
coupling parameters and establishing a standardized set of parameter configurations for
subjects to begin from. Subjects in this study walked through a series of ambulation tasks
while a clinician tuned the lower dimensional space of parameters accordingly. The tuning
of these parameters was based upon a combination of visual inspection of kinematics by
the clinician and user feedback. In testing with 6 subjects (3 experienced, 3 novice), they
found that their methods allowed for adequate tuning of the device by only changing col-
lectively 21 and 24 parameters for the experienced and novice users, respectively. The time
required to tune the device was 2.5-5 hours depending on the subject. Through this work,
Simon et al. were able to show that their techniques could drastically reduce the number of
parameters needed to be tuned by a clinician fitting a subject with such a complex device.
Although this was not an autonomous tuning, this study represents an important step in
improving the tuning time for an extremely complex device.
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Another means of feedback guided tuning was presented by Caputo et al. [27]. In
this study, researchers attempted to simultaneously tune three separate parameters of a
tethered powered ankle prosthetic by explicitly using only user feedback. The controller
of interest simulated spring like behavior (net-zero work) and the tuning parameters were
resting angle, stiffness, and shape (stiffening or softening) of the virtual spring [29]. In this
study, an experimenter would begin subjects at a randomized parameter configuration and
then deviate one of the three parameter configurations in a randomized direction until the
subject reported a decrease in satisfaction. The experimenter would then reverse directions
until the subject again reported a decrease in satisfaction. This process was repeated for a
total of three reversals. The best parameter configuration for this deviation task was taken
to be the mean of the midpoints of the final reversals in each direction. This process was
then repeated for the next parameter setting and done in total three times for each parameter.
This methodology created a hill climb optimization routine that zeroed in on a parameter
configuration that optimized for user satisfaction [115]. The only publication to date on this
work shows preliminary findings from a small sample size of 3 transtibial amputees [27];
however, the presented results are quite intriguing. Caputo et al. showed that although
there was no large difference in metabolic work rate of the optimized tethered prosthesis
compared to subjects’ prescribed prosthesis, subjects showed an average decrease in net
heart rate, an increase in maximum walking speed, and an increase in user satisfaction
scores with the optimized prosthesis compared to their prescribed prosthesis. This study is
a great example of alternative cost landscapes that can be used to tune a device and how
a form of optimization can be used to direct a multidimensional tuning. It is worth noting
that this optimization routine was based purely on subjective information provided by the
user and was not autonomously driven.
Autonomous Tuning of Devices
Research conducted by Huang et al. demonstrates an early example of an autonomous
tuning strategy that is based upon objective gait measurements taken from the device during
walking [73]. Although these are objective measurements, the adaptive tuning of this work
was based upon subjective decisions and control laws. Huang has coined this type of tuning
as a cyber expert tuning. For this study, researchers tuned a impedance based controller for
a powered knee-passive ankle prosthesis [98]. Given 3 tuning parameters (virtual spring
stiffness, resting angle, and damping coefficient) with 5 discrete states of the stride cycle,
a total of 15 parameters needed to be tuned. Two able bodied subjects using a bypass
and one amputee subject were first tuned in the device by a human expert. The cyber
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expert was then designed using fuzzy logic control with a number of logic rules (IF-THEN
statements) developed by means of observing the human expert tuning. These logic rules
were based upon objective measures of peak knee angle, gait phase duration, and peak knee
angular velocity; however, the action of the logic rules were based upon observed subjective
opinions of the human expert tuning. Once designed, the cyber expert was tested by tuning
the device for the three subjects in which it was designed around along with one new subject
(amputee) to test its performance on a naive subject. Results showed that the cyber expert
tuning was able to tune the device toward normal gait kinematics in about half the time of
that required by the human expert it was designed around (∼188 versus ∼96 strides) and
without any human intervention. This type of tuning approach can potentially allow for
autonomous and more objective tunings that can be performed outside of the clinic setting
on a more frequent basis for the user.
Similar to Huang et al.’s work, work by Spanias et al. has shown that autonomous
tuning based upon objective mechanical measurements is also possible using a machine
learning approach [125]. Although in this work pattern recognition for the discrete change
in ambulation modes of a device was the targeted tuning, one could imagine this can also
be applied towards the tuning of continuous control parameters much like that in Huang
et al.’s work. The benefit of Spanias et al.’s approach over Huang et al.’s is that control
laws do not need to be explicitly identified by the designer which can be a very time con-
suming process and relies on an expert’s opinion which can be subjective from one expert
to another. Additionally, a machine learning approach can potentially identify tuning laws
that would be unintuitive for a researcher to identify [15]. Given enough data to train on, a
machine learning approach should identify tunings completely autonomously based upon
objective measures.
1.3 Contributions
In all of the presented state of the art literature, all tuning approaches were based upon me-
chanical measurements taken directly from the device or subjective user feedback. How-
ever, these devices are often analyzed and evaluated using physiological measures taken
directly from the user. Currently, there is a large disconnect between state of the art tuning
approaches and evaluation approaches. This dissertation aims to bridge this gap by basing
all tunings upon objective physiological measures. To the best of my knowledge, the work
of this dissertation serves as the first real-time tuning and adaptation of an assistive device
based upon an objective physiological measure.
The content of this dissertation is broken into four major chapters. In Chapter 2, I have
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discussed methods that improve upon the current standards of processing and analyzing
metabolic work rate data. In this work, I have developed a generalized analysis of non-
steady-state measures of metabolic work rate. This approach preserves the noise content
of the energetic measures and allows for novel confidence analyses of identified cost land-
scapes. Additionally, I have experimentally tested these techniques and have rigorously
proven their feasibility. In doing so, I have also compared them to current standard prac-
tices in the field. In Chapter 3, I applied the techniques presented in Chapter 2 to conduct
a real-time optimization of powered bilateral ankle exoskeletons. For this work I used a
gradient descent optimization to optimize an actuation timing parameter of these simple
exoskeletons on a subject-specific basis. This was the first ever example of an online op-
timization of an assistive robotic device driven by measures of metabolic work rate. In
Chapter 4, I have investigated how users may use and adapt to using an adaptive controller
where they have a more direct impact on the adaptation of the device. In this study, I
designed an adaptive gain proportional myoelectric controller and tested it with healthy
subjects walking in bilateral ankle exoskeletons. The controller itself adapted to maintain
maximal power output regardless of users’ muscle recruitment allowing the wearers own
nervous system to adapt to how it would like to use the device. Results from this work
showed that users adapted to joint mechanics that were not biologically feasible without
the added assistance. These results suggest that designing controllers to mimic healthy
biomechanics may not be the best approach to controller design as users seem to adapt to
abnormal joint dynamics when given the freedom to do so. Lastly, in Chapter 5 I have
compared how subjects may use a controller driven by neural signals differently than one
driven by mechanically intrinsic signals. Given that I have presented two different adaptive
controllers in the previous chapters, one driven by mechanically intrinsic signals and the
other by neural signals, it is an interesting question to ask that if each were to adapt to the
same actuation signal, would subjects use each controller differently? The results of this
project suggest that control based on neural signals may be better suited for therapeutic
rehabilitation than control based on mechanically intrinsic signals due to different levels of
slacking by the users.
As a whole, the collection of work presented in these four chapters has drastically
improved upon subject-specific control of assistive devices. These improvements have
been made through contributions in novel adaptive controllers and rigorous analysis of
how users adapt to using them. It is my hope that this work will lay foundation for many
future advancements and studies to come.
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CHAPTER 2
Confidence in the Curve: Establishing
Instantaneous Cost Mapping Techniques using
Bilateral Ankle Exoskeletons
2.1 Introduction
There are many ways to evaluate lower extremity assistive robotic devices. Most com-
monly, the field relies on measures of metabolic power to assess device performance [38,
106,147]. Since these devices are designed to aid in locomotion, we would expect a reduc-
tion in users’ metabolic power when walking in them. Until a few years ago, the evaluation
of assistive robotic devices was limited to merely determining if a reduction in metabolic
power was achieved or not [7,32,66,116,136]. However, more recently, the field has started
to investigate in detail the quantitative relationships between various device control param-
eters and the users’ metabolic power. In the context of lower extremity assistive devices,
these control parameters may define things such as actuation timing, torque and power out-
put, or virtual stiffness and damping of a device [77,92,108]. In current devices, more than
a dozen parameters may exist and must be tuned on a subject-by-subject basis for a variety
of different tasks [14,93]. This tuning is important, since the performance of many devices
is sensitive to these parameter configurations. In many cases, there exists an optimal config-
uration that results in the largest reduction in metabolic power. These devices can result in a
10-26% reduction in metabolic power when optimally tuned compared to their unpowered
configurations [28, 51, 77, 101, 102, 108]. We refer to the functional relationship between
the device parameters and the associated metabolic power as the metabolic cost landscape.
As subject-specific parameter tuning is becoming increasingly relevant, systematic meth-
ods to quickly and accurately identify metabolic cost landscapes are becoming more and
The content of this chapter has been previously published in the Journal of Applied Physiology [88].
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more important.
Our field’s current standard to identify a metabolic cost landscape is to measure users’
respiratory gas exchange during a brute force parameter exploration. To this end, users walk
in a device with a given parameter configuration until measured metabolic power reaches
a steady state. This can take multiple minutes due to inherent sensor dynamics associated
with respiratory measurements [139]. These dynamics are the result of a time delay be-
tween instantaneous energetic demand by the body and oxygen consumption measured at
the mouth. Once a steady state is reached, a few minutes of metabolic data are collected for
analysis. Such long data collections are required since measurements of oxygen uptake and
carbon dioxide output are inherently noisy, having a signal to noise ratio of approximately
4, and are sparsely sampled, having a sample rate of approximately 0.32 Hz [18, 91, 139].
Researchers repeat this collection process for each parameter configuration across the pa-
rameter space of interest, average the steady-state breath measurements, and fit a curve to
the averaged data points. This curve describes the subjects’ metabolic cost landscape.
There are a number of limitations to this standard practice. First, a brute force explo-
ration that relies on steady-state measures can be time consuming and taxing on both the
subject and the researcher or clinician, especially when the parameter space is multidimen-
sional [14, 51, 93]. A lengthy time requirement on device tuning and evaluation can also
be problematic when clinical populations, such as people post-stroke or with amputation,
are the end users. Many of these clinical users might not have the ability or strength to
walk for the long intervals required to conduct this type of parameter exploration. Addi-
tionally, all information about inter-breath variability is lost when data is averaged during
post-processing. This can lead to a false sense of accuracy in the measurements and curve
fits.
We refer to this standard practice of using only steady-state measurements in estimating
a cost landscape as a steady-state cost mapping analysis. In recent years, researchers have
started to work on viable alternatives to this steady-state cost mapping analysis [118]. In
our own work, we proposed an instantaneous cost mapping analysis that takes into account
the sensor dynamics of the metabolic system when post-processing data [43]. This enables
the use of all breath measurements, including those recorded not at a steady state, to esti-
mate the metabolic cost landscape. In doing so, the instantaneous cost mapping analysis
allows for a more rapid parameter exploration to back out an estimate of the metabolic cost
landscape.
In this paper we present methodology for subject-specific metabolic cost landscape con-
fidence analyses. These techniques calculate a confidence band on estimated landscapes
and a probability distribution of where the minimizing parameter configuration may lie on
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a subject-specific basis. These methods allow for a rigorous comparison of mapping pro-
tocols among one another and display how subject-specific measurement noise can affect a
given fit. To verify these methods, we applied them to estimating subject-specific metabolic
cost landscapes as a function of actuation onset for bilateral ankle exoskeletons (Fig. 2.1).
We tested 9 healthy subjects in the exoskeletons using a step and a ramp parameter ex-
ploration of the devices’ actuation onset. We analyzed both of these explorations using an
instantaneous cost mapping analysis and compared the results to the current standard in
the field, a step exploration with a steady-state cost mapping analysis. These comparisons
clearly illustrate the trade offs associated with different parameter exploration protocols
and mapping analyses, comparisons only made possible by the presented confidence tech-
niques.
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Figure 2.1: Proposed human subject testing to validate confidence in the curve techniques.
Here we are presenting a generalized instantaneous cost mapping analysis and novel metabolic cost
landscape confidence analyses. We verified these techniques using bilateral ankle exoskeletons
where we estimated subject-specific metabolic cost landscapes as a function of the exoskeletons’
actuation onset timing. We tested a step and ramp parameter exploration and analyzed each using
an instantaneous cost mapping analysis. These results were compared to a step exploration with a
steady-state cost mapping analysis, the current standard in the field.
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2.2 Methods
2.2.1 Mapping of a Metabolic Cost Landscape
The goal of any metabolic cost mapping protocol is to extract an estimate of the body’s
metabolic demand, x, as a function of the device control parameters, p. Mathematically,
we denote this metabolic cost landscape as x(p). x is also known as the instantaneous
energetic cost [118]. It is established practice in the field of assistive robotic devices to use
linear combinations of basis functions to describe x(p). For example, linear combinations
of monomials are commonly used to describe x(p) as a polynomial function [28, 33, 101,
119]. Using a linear combination of basis functions is a deliberate choice to simplify the
metabolic cost landscape and thus form a more tractable problem. Although linear with
respect to the chosen basis functions, these curves can still be highly nonlinear given the
choice of basis functions used.
2.2.2 Representing an Estimate of the Metabolic Cost Landscape
Any fitted curve that is linear with respect to a set of basis functions can be expressed as
x¯(λ,p) =
m∑
j=1
g(p)jλj = g(p)
>λ, (2.1)
where x¯(λ,p) represents the functional estimate of the true underlying metabolic cost land-
scape x(p). In this representation, λ is a m× 1 vector of scalar coefficients and g(p) is a
m× 1 vector of basis functions evaluated at p. g(p)j and λj are simply the j th elements of
the vectors g(p) and λ, respectively.
Consider, for example, a second order polynomial curve with a single parameter, p = p:
x¯(λ,p) = λ1 + λ2p+ λ3p
2. (2.2)
We can describe the above in the format of Eq. (2.1) such that the vector of basis functions,
g(p), is defined as
g(p) = [g(p)1, g(p)2, g(p)3]
>
=
[
1, p, p2
]>
.
(2.3)
Similarly, a second order polynomial curve with two parameters, p = [p1, p2]
x¯(λ,p) = λ1 + λ2p1 + λ3p2 + λ4p1p2 + λ5p
2
1 + λ6p
2
2, (2.4)
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is defined via the vector of basis functions
g(p) = [g(p)1, g(p)2, g(p)3, g(p)4, g(p)5, g(p)6]
>
=
[
1, p1, p2, p1p2, p
2
1, p
2
2
]>
.
(2.5)
By representing curve fitting functions as a linear summation of basis functions, we are
able to generalize the following mathematics so that these techniques can be applied to any
dimensionality of parameter space or function order. It is worth noting that the choice of
basis functions is not constrained to monomials. Other basis functions, such as exponential
or trigonometric functions, can also be used. However, in the realm of assistive devices,
monomial are the predominant choice [28, 33, 101, 119].
2.2.3 Measuring x(p)
The metabolic cost landscape, x(p), is commonly estimated by measuring oxygen con-
sumption via respiratory measurements of oxygen uptake and carbon dioxide output [19].
These respiratory measurements give us the correct estimate of x(p) during steady-state
activity; however, there are significant sensor dynamics associated with this process that
prevent us from measuring x(p) during non-steady-state activity. These sensor dynam-
ics are due to an inherent time delay between the body’s instantaneous energetic demand
and physical respiratory measurements. Muscles generate mechanical work through the
breakdown of adenosine triphosphate at the cross bridge level. Replenishment of adeno-
sine triphosphate through oxidative phosphorylation takes longer than anaerobic reactions
and depends on red blood cell transport to the muscle. Changes in cardiac output and respi-
ration rates are not instantaneous and create time lags between energy usage and resupply.
In addition, respiratory measurements only sample a portion of the air volume within the
lung with each breath causing further time delay as content of the total lung volume does
not instantaneously reach an equilibrium that reflects the oxygen and carbon dioxide con-
tent of the blood. The dynamics of the human metabolic system can be modeled as a first
order system with a time constant of approximately 40 seconds during walking. Exact time
constant values vary on a subject-specific basis [118].
yi =
(
1− hi
τ
)
yi−1 +
hi
τ
x(pi). (2.6)
In this representation, yi is the metabolic power estimated from breath measurement i, hi
is the elapsed time since the previous breath, τ is a subject-specific time constant, and pi is
the parameter configuration enforced during breath i.
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2.2.4 Metabolic Cost Mapping Analyses
In the following sub-sections we have defined the mathematics behind the steady-state cost
mapping (SSCM) and instantaneous cost mapping (ICM) analyses using the aforemen-
tioned notation of basis functions. We have expressed each analysis in the form of a single
matrix equation so we can apply generalized confidence analyses to each as described in
the following section.
2.2.4.1 Steady-State Cost Mapping Analysis
A SSCM analysis relies solely on steady-state measurements of metabolic power to fit the
best x¯(λ,p). Therefore a SSCM analysis can only be used with a parameter exploration
protocol that holds a parameter configuration constant long enough for metabolic measures
to stabilize before moving onto another configuration. The best x¯(λ,p) is one that rep-
resents steady-state energy consumption with as little error as possible. This is described
mathematically as minimizing the sum of squared error between x¯(λ,p) and actual breath
measurements, yˆi, over n steady-state breaths,
min
λ
n∑
i=1
(x¯(λ,pi)− yˆi)2 . (2.7)
We can solve Eq. (2.7) using linear regression techniques. We begin by expanding out
Eq. (2.1) into a matrix format where each row is an individual steady-state breath recorded
during the parameter exploration
g(p1)1 g(p1)2 · · · g(p1)m
g(p2)1 g(p2)2 · · · g(p2)m
...
...
...
g(pn)1 g(pn)2 · · · g(pn)m


λ1
λ2
...
λm
 =

x¯(λ,p1)
x¯(λ,p2)
...
x¯(λ,pn)
 , (2.8)
or simplified to the matrix equation
ASSCMλ = x¯. (2.9)
In this notation, ASSCM is a n×m matrix where n ≥ m, and x¯ is a n× 1 vector of x¯(λ,pi)
values for i = 1 . . . n. By considering all yˆi as the n× 1 vector yˆ, we can substitute yˆ and x¯
into equation Eq. (2.7) to solve for the vector λ? that minimizes the measurement residuals.
This results in
λ? = A+SSCMyˆ, (2.10)
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where A+SSCM is the left pseudo-inverse of ASSCM defined as A
+
SSCM = (A
>
SSCMASSCM)
−1A>SSCM.
By definition, λ? describes the optimal estimate of the cost landscape, x¯(λ?,p).
This process is slightly different than the standard in the field in which the steady-state
metabolic data are post-processed by averaging breath measurements from each individual
p configuration prior to fitting a curve to these averaged points. This averaging process
eliminates any notion of inter-breath variability; however, including this variability is im-
perative for establishing curve confidence. The SSCM analysis that we have presented here
excludes this averaging step by considering each individual steady-state breath in the fit-
ting of x¯(λ?,p) and thus includes inter-breath variability in the matrix equation. If each
parameter configuration being considered in a SSCM analysis contains the same number of
breath measurements, then the standard of averaging the data results in the same x¯(λ?,p)
as considering each individual breath as presented here.
2.2.4.2 Instantaneous Cost Mapping Analysis
An ICM analysis takes into consideration the dynamic model of the human metabolic sys-
tem when estimating a metabolic cost landscape. Therefore an ICM analysis can be used
with any continuous parameter exploration protocol without the explicit need of ever reach-
ing steady-state energy consumption [43, 118]. By substituting Eq. (2.1) into Eq. (2.6),
we derive a function for estimated individual breaths, y¯i, that incorporates the underlying
metabolic dynamics,
y¯i =
(
1− hi
τ
)
y¯i−1 +
hi
τ
g(pi)
>λ. (2.11)
A visual example of this model is shown in Fig. 2.2.
During an ICM analysis, we are seeking an x¯(λ,p) that minimizes the error between the
estimate of each measure, y¯i, and the actual measure, yˆi, across a series of n, not necessarily
steady-state, continuous breaths. This is described mathematically as minimizing the sum
of squared error between the estimated and the actual measurements,
min
λ
n∑
i=1
(y¯i − yˆi)2 . (2.12)
We can solve for Eq. (2.12) by expressing Eq. (2.11) in a matrix notation. If we expand out
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Figure 2.2: Modeling the human metabolic system as a discrete, time-delayed first order
system. There is an inherent time delay between an instantaneous change in energetic demand by
the body and the measured oxygen consumption at the mouth. We have considered these metabolic
sensor dynamics as a first order system which allows us to use all recorded breath measures in an
instantaneous cost mapping analysis, regardless of whether the measures are at a steady state or not.
Here is a representative example of this model given a step change in actuation onset timing for a
set of pneumatically powered ankle exoskeletons (change from po = 0.28 normalized stride time
to pf = 0.58 normalized stride time). The identified time constant τ for this representative subject
was 51.9 seconds. These exoskeletons are further described in later sections.
Eq. (2.11) for individual breaths it can be expressed as
AICM

y¯1
λ1
...
λm
 =

y¯1
y¯2
...
y¯n
 , (2.13)
where AICM is generated recursively as
AICMi,j=

1 i=1, j=1
0 i=1, j>1
AICMi−1,j
(
1−hi
τ
)
i>1, j=1
AICMi−1,j
(
1−hi
τ
)
+hi
τ
g(pi)j−1 i>1, j>1
. (2.14)
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Each row of AICM corresponds to an individual breath estimate based upon previous breaths
due to the architecture of Eq. (2.11). In the above notation, AICM is a n×m+ 1 matrix
where n ≥ m+ 1. We can express this linear relationship more simply as the matrix equa-
tion
AICM
[
y¯1
λ
]
= y¯, (2.15)
where y¯ is a n× 1 vector of y¯i values for i = 1 . . . n. We can now solve for the optimal y¯1
and λ by substituting Eq. (2.15) into Eq. (2.12) and considering all yˆi as the n× 1 vector
yˆ. Solving for the optimum results in[
y¯?1
λ?
]
= A+ICMyˆ, (2.16)
where A+ICM is the left pseudo-inverse of AICM defined similarly to A
+
SSCM. By definition, λ
?
describes the optimal estimate of the underlying cost landscape, x¯(λ?,p).
2.2.5 Confidence in the Curve
The described cost mapping analyses will always solve for the optimally estimated cost
landscape, x¯(λ?,p), given the appropriately corresponding experimental data, yˆ. How-
ever, these estimates alone say nothing about how well the optimal fit truly describes the
collected data. This makes it difficult to conclude anything about the confidence in a fit or
compare mapping analyses to one another. In the following, we present methodology that
asses confidence in the resulting curve of any mapping analysis on a subject-specific basis
so long as the analysis can be described by a matrix equation that is linear with respect
to the estimated underlying basis functions, much like Eq. (2.9) and Eq. (2.15). These
methods solve for a confidence band about x¯(λ?,p) and calculate a probability distribu-
tion of where the corresponding minimizing parameter configurations may lie. We first
describe the confidence on our optimally estimated breaths and optimal linear coefficients
before making the transition to confidence on x¯(λ?,p) as these are the building blocks to
establishing confidence on the fitted curve.
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2.2.5.1 Confidence in Optimally Estimated Breaths
At the foundation of evaluating curve confidence is the confidence in the individual breath
measurements. This is described by a fit’s unbiased variance, or s2 [144]:
s2 =
1
n− d ||yˆ − y¯
?||22. (2.17)
Here, d represents the degrees of freedom in any given fit. In the context of this paper, the
SSCM analysis has d = m (fitting λ) while the ICM analysis has d = m+ 1 (fitting λ and
y¯1). In Eq. (2.17), y¯? represents the optimally estimated breath measurements. These are
the estimates that arise from evaluating an analysis’ matrix equation using the identified
optimal fitting parameters. For example, given a SSCM analysis, y¯? would be the result of
substituting the solved for λ? into Eq. (2.9). Alternatively, for an ICM analysis, y¯? would
be the result of substituting the solved for λ? and y¯?1 into Eq. (2.15). By considering the
variance in estimated breaths versus real breaths, we are making the implicit assumption
that respiratory measurements are characterized by Gaussian white noise. This is an as-
sumption that has previously been established [91]. Because s2 is a measure of variance
between the optimally estimated breaths and the actual recorded breaths, it is intuitive that
data with larger noise content will lead to larger variance and thus less confidence in a given
fit. Establishing confidence on y¯? is a purely linear process since it is based on a linear fit.
2.2.5.2 Confidence in λ?
Confidence in the optimally fitted linear coefficients, λ?, is characterized by a covariance
matrix, Σ:
Σ = s2
(
C
(
A>A
)−1
C>
)
. (2.18)
In this equation, A is the matrix from a given mapping analysis’ matrix equation, such
as ASSCM or AICM, and C is a selection matrix used to indicate which fitted variables to
consider in the confidence analysis [144]. It should be noted that Eq. (2.18) is dependent
upon A and s2. s2 is a scalar value that only depends on the inter-breath variability for a
given subject while A is a matrix whose architecture is highly dependent upon the chosen
parameter exploration. Therefore, Σ can be largely characterized based upon the parameter
exploration chosen for a given mapping analysis. C is only included in Eq. (2.18) so that
fitted variables that may not be represented in the optimal curve x¯(λ?,p) can be omitted
from the confidence analyses. In the case of the ICM confidence analysis, we do not wish
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to consider y¯?1 in the analysis since it is not actually represented in x¯(λ
?,p). In this scenario
C =
[
0m×1 Im×m
]
. (2.19)
In the case of the SSCM analysis, C is simply a m×m identity matrix.
To establish a confidence region on λ?, we can consider the following [144]:
(λ− λ?)>V(λ− λ?) ≤ 1, (2.20)
where
V = (F(M + 1)Σ)−1 . (2.21)
In Eq. (2.21), F is the F-statistic of the fit given some chosen critical point. For example,
to establish a 95% confidence region, a 5% critical point should be used. In calculating F ,
the numerator is defined as the degrees of freedom used in the given fit minus one, d − 1,
while the denominator is defined as the number of data points minus the degrees of freedom
used in the given fit, n − d. Geometrically, Eq. (2.20) can be thought of as a confidence
ellipsoid in the λ coordinate space centered about λ?. Any λ that satisfies Eq. (2.20) is a
point that lies within the ellipsoid and thus within the confidence region. The inverse square
roots of the eigenvalues of V describe the magnitude of the ellipsoid’s principal axes and
the corresponding eigenvectors describe the ellipsoid’s orientation in space. Establishing a
confidence region on λ? is a purely linear process.
2.2.5.3 A Confidence Band on x¯(λ?,p)
From Eq. (2.1) we see that λ? directly shapes the optimally fitted curve, x¯(λ?,p). By
establishing a confidence region on λ?, we have inherently established a confidence region
on x¯(λ?,p). Despite the fact that the fitted curve can be nonlinear due to the basis functions,
the curve is still linear with respect to λ so we can map the confidence region between the
two spaces in a purely linear fashion. To do so, we must consider the confidence band’s
upper and lower edges at individual parameter configurations across our parameter space.
We will denote an individual query parameter configuration as p◦. At each p◦ there exists
a vector of linear coefficients, λ◦, whose corresponding curve touches the upper or lower
edge of the confidence band at that specific point. To solve for λ◦, consider the following
optimization problem:
max/min
λ◦
g(p◦)> (λ◦ − λ?)
subject to (λ◦ − λ?)>V(λ◦ − λ?) ≤ 1
. (2.22)
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This optimization aims to maximize or minimize the difference between x¯(λ◦,p◦) and
x¯(λ?,p◦) subject to λ◦ being within or on the surface of the defined confidence ellipsoid.
The analytic solution to this extremal problem statement is
λ◦max/min = λ
? ± V
−1g(p◦)√
g(p◦)>V−1g(p◦)
(2.23)
where the ± accounts for a maximization and minimization of the presented optimization
problem, respectively. A proof of this analytic solution is provided in the appendix. Ge-
ometrically, this solution is equivalent to establishing a line in the λ coordinate space that
points in the the direction of V−1g(p◦) and passes through the origin of the ellipsoid de-
scribed by V. The solutions for λ◦max/min are the two points where this line intersects with
the ellipsoidal surface. This optimization only gives us a vector λ◦; however, evaluating
g(p◦)>λ◦ will give us an x¯ point at the edge of the confidence band. Repeating this calcu-
lation for every p◦ along our parameter space of interest allows us to compute x¯ points that
define the edges of the confidence band about x¯(λ?,p).
2.2.5.4 Confidence in the Minimizing Parameter Configuration
We commonly estimate a metabolic cost landscape in order to identify the optimal param-
eter configuration that minimizes metabolic power. We will denote this optimal parameter
configuration as p?. The process of mapping from the confidence on x¯(λ?,p) to a proba-
bility distribution of where p? may lie is a nonlinear process as the fitted function may have
more than one minimum location, a minimum location at negative infinity, or a minimum
location that may lie outside of the evaluated parameter space. For this reason, we have de-
veloped a Monte Carlo approach to establishing a p?-probability distribution to overcome
this nonlinearity.
Given λ? and Σ, we generate a multivariate random Gaussian distribution of linear
coefficient vectors. Each of these randomly generated vectors, λ, are then evaluated with
Eq. (2.20) to see if they lie in the confidence region of λ?. Any λ that violate Eq. (2.20)
are disregarded as they lie outside of the confidence region. The remaining λ are then used
to generate their corresponding curves, x¯(λ,p), and evaluated across the parameter space
of interest. Once a curve is established across the parameter space, the curve’s p? location
is identified as the parameter configuration corresponding the minimum x¯ point and then
binned accordingly. The final binned values are normalized such that the cumulative sum
is 1 in order to establish a probability distribution. From this p?-probability distribution we
calculate a mean and standard deviation.
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Figure 2.3: Example of how the covariance matrix affects the cofidence analysis. To illustrate
our methodology, these examples highlight the effects of the covariance matrix on the confidence
analysis of a metabolic cost landscape. This is a cartoon example of a second order polynomial
describing an arbitrary, but realistic, underlying metabolic cost landscape. The shaded region in
each figure is the 95% confidence band about the optimally fitted polynomial. The point and bars
below each p?-probability distribution represent the mean± 1 standard deviation of the distribution.
In (A) the covariance matrix is a scaled identity matrix. All following sub-figures are depictions of
small deviations from this covariance matrix. In (B) we increased the diagonal component that
corresponds with λ1 (the vertical offset of the curve) by an order of magnitude. This widens the
confidence band in the vertical direction but has no effect on the probability distribution of the
minimum location. In (C) we increased the diagonal component that corresponds with λ2 (the
slope of the curve) by an order of magnitude. This widens the confidence band at larger slopes
and greatly expands the probability distribution of the minimum location. In (D) we increased the
diagonal component that corresponds with λ3 (the convexity of the curve) by an order of magnitude.
This widens the confidence band at parameter settings relatively far from the minimum location and
has a small effect on the probability distribution of the minimum location.
2.2.5.5 Example of Confidence Techniques
Both the confidence band on x¯(λ?,p) and the probability distribution of the minimizing pa-
rameter configuration are driven by the covariance matrix Σ. To better show how Σ affects
the confidence of a fit, we present a simple example illustrated in Fig. 2.3. Suppose that
we have predicted an underlying metabolic cost landscape as a second order polynomial.
After performing the fit we found
x¯(λ?,p) = 3 + p2, (2.24)
meaning λ? = [3, 0, 1]>. Fig. 2.3 highlights different possible covariance matrices, Σ, to
show how each can affect the confidence of this fit in a different manner. It is important to
note that in each scenario of this figure we always have the same x¯(λ?,p), yet very different
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confidence results depending on the corresponding covariance matrix. For simplicity, we
have only considered terms on the diagonal of Σ for this example. In calculating F , we
have arbitrarily chosen n = 100 and used a critical point of 5%, thus illustrating the 95%
confidence region. We computed 105 Monte-Carlo roll-outs using a multivariate Gaussian
generator with Σ and λ? as inputs to calculate the p?-probability distributions.
2.2.6 Validation Study with Ankle Exoskeletons
To validate our mapping and confidence analyses, we tested 9 healthy male subjects using
bilateral pneumatically powered ankle exoskeletons. We tested with only male participants
due to the shoe size requirement of the exoskeleton design. We deemed one subject as
an outlier due to inexplicably noisy respiratory measurements (a signal to noise ratio of
approximately 2 where the healthy average is approximately 4 [139]). Data from the 8
remaining subjects are presented here (age: 23±6 years; body mass: 72.2±5.3 kg; height:
179.4± 7.7 cm; mean ± s.d.). All testing was in accordance to the University of Michigan
Medical Schools Institutional Review Board and all subjects gave informed written consent
to participate in the study prior to testing.
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Figure 2.4: Exoskeleton controller used for experimental validation of confidence analyses.
The exoskeleton control was based on an “on-off” control law driven by the user’s normalized stride
time, S. When the user’s normalized stride time surpassed the actuation onset threshold, p, a control
signal was sent to the pressure valves to turn the pneumatic muscles on. The muscles were turned off
again once the controller detected toe off, STO. The timing of actuation onset (encoded in p) was the
parameter that was explored during testing. Its impact on users’ metabolic power was characterized
in the associated cost landscape.
The ankle exoskeletons used in this study had one degree of freedom to allow for users
to move their ankles freely in plantar and dorsiflexion. The exoskeletons only assisted in
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plantar flexion during the stance phase of the gait cycle. The pneumatic actuators were
triggered into an on state by the users’ normalized stride time, S, surpassing an actuation
onset threshold, p 2.4. We defined S such that S = 0 represented heel strike while S = 1
represented the following heel strike of the same leg. Actuation was triggered into an off
state upon toe off detection. The actuation onset threshold, p, was the control parameter
that was varied in exploration protocols in order to estimate its effect on the metabolic
power of the user. The hardware for these devices was custom built and designed based
upon previous work done by Ferris et al. [44] while the control scheme was based upon
work done by Malcolm et al. [101]. Further information about the exoskeleton hardware
and control was previously presented by Koller et al. [87, 89].
All subjects were tested with two different parameter exploration protocols, a step ex-
ploration and a ramp exploration (Fig. 2.5). The step exploration tested a number of
discrete settings of p in a randomized order and stayed at each setting for 6 minutes. This
type of exploration is the standard practice in the field to collect data for a SSCM anal-
ysis [28, 33, 51, 87, 101, 102, 119]. The ramp exploration varied p continuously over the
course of 16 minutes in a bidirectional ramping profile. We conducted a SSCM analysis on
the data from the step exploration and an ICM analysis on both data sets.
All participating subjects walked in the exoskeletons on two days. The first day served
as a training day for subjects to adapt to the exoskeletons and followed the same protocol
as the second day. The second day served as the actual data collection and the results
presented here only contain data from this day of testing. During testing, each subject
completed the step and the ramp parameter explorations in a randomized order. Subjects
were given 5-10 minutes to walk in the exoskeletons at the start of each day to assess
exoskeleton fit and allow subjects to familiarize themselves with the devices. Data were
collected while walking at a constant speed of 1.2 ms-1 on an instrumented treadmill (Bertec
Corporation, Columbus, OH) and subjects rested in a seated position for 10-20 minutes
between exploration protocols. We used a portable open-circuit indirect spirometry system
(CareFusion Oxycon Mobile, Hoechberg, Germany) to measure oxygen uptake and carbon
dioxide output during testing. We used formulas from Brockway [19] to convert these
measurements to metabolic power and normalized measures by subjects’ individual mass.
During testing, we monitored subject’s respiratory exchange ratio (RER) to ensure that
it remained in an aerobic state (RER<1). In addition to the parameter explorations, all
subjects completed a 4 minute standing trial of which the final 3 minutes were averaged to
calculate subject’s standing metabolic power. All measures of metabolic power presented
in this paper have the subject’s standing metabolic power subtracted to represent their net
metabolic power.
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Figure 2.5: Exploration and analysis protocols used in experimental validation of confidence
analyses. We considered three combinations of parameter exploration and data analysis. In all
sub-figures, the bold lines represent data from the corresponding exploration that were used in
the analysis. (A) is a step exploration with a SSCM analysis. This is the standard protocol for
exploration and analysis in the field of assistive robotic devices. (B) is a step exploration with
an ICM analysis. Although this is the same parameter exploration as the standard practice, the
ICM analysis allows for the use of steady and non-steady-state data to estimate the metabolic cost
landscape. (C) is a ramp exploration with an ICM analysis. During this exploration the parameter
configuration is varied in a continuous ramping manner meaning no metabolic steady state is ever
reached once the ramping has started.
2.2.6.1 Step Exploration
Subjects walked at 9 powered conditions during the step exploration. Each condition lasted
for 6 minutes before transitioning to the next. We gave subjects verbal warnings before
starting the treadmill, powering on the exoskeletons, and powering off the exoskeletons.
There were 7 different parameter settings (p = 0.13, 0.21, 0.28, 0.36, 0.43, 0.51, and 0.58
normalized stride time) that subjects experienced during the 9 different powered condi-
tions. The 1st, 5th, and 9th powered conditions were repeated as p = 0.58 normalized stride
time while intermediate powered conditions were randomly chosen from the remaining p
values. We repeated the parameter setting for the 1st, 5th, and 9th powered conditions to
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observe learning effects and fatigue in subjects throughout the protocol. For all subjects,
the differences in these steady-state values were within the expected measurement noise of
users’ metabolic power and thus we have concluded that no significant learning or fatigue
took place. We chose p = 0.58 normalized stride time for this repeated parameter setting
because this setting triggered the on state for the shortest amount of time. In doing so, we
were able to ease subjects in and out of powered conditions in the safest and smoothest way
possible.
The step exploration data was analyzed using both a SSCM analysis and an ICM analy-
sis. For both analyses we only considered data from powered conditions 2-8. We excluded
the 1st and 9th powered conditions from the analyses as to not overweight p = 0.58 nor-
malized stride time in the curve fitting process. We considered steady-state data collected
in the final 3 minutes of each powered condition for the SSCM analysis. We considered
all powered data for the ICM analysis. In total, the step exploration protocol required 54
minutes of powered walking time per subject. 21 minutes of data were used in the SSCM
analysis while 42 minutes of data were used in the ICM analysis. Example time series plots
of the powered conditions for the step exploration with corresponding analyses are shown
in Figures 2.5A and 2.5B.
2.2.6.2 Ramp Exploration
For the ramp exploration, we had subjects begin by walking at a randomized extreme of
the parameter space (p0 = 0.13 or p0 = 0.58 normalized stride time) for 4 minutes to allow
them to reach a metabolic steady-state. The initial parameter setting was then ramped
across the parameter space from p0 to the opposite extreme, pext, over the course of 8
minutes. After reaching pext, the parameter setting was then ramped back to p0 over the
course of another 8 minutes. Therefore the parameter at breath i, pi, was a function of time
t (in seconds) since the ramping procedure had begun:
pi =

3t
3200
+ p0 if t ≤ 480
1440− 3t
3200
+ pext if t > 480
. (2.25)
We chose to use a bidirectional ramping procedure as it has been shown to decrease error in
the identified p? location if there is an error in the estimated subject-specific time constant,
τ [75].
We analyzed the ramp exploration data with an ICM analysis using only data collected
during the actual ramping procedure. Therefore, the protocol required 20 minutes of pow-
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ered walking per subject, and 16 minutes of data were used in the analysis. A time series
plot of the powered conditions for the ramp exploration with an ICM analysis is shown in
Fig. 2.5C.
2.2.6.3 Estimating subject-specific τ
The computation of AICM requires a subject-specific time constant, τ . There are a number
of ways to estimate a subject-specific τ [43, 118]. We chose to compute τ from the read-
ily available step exploration data. We averaged the data from the final 3 minutes of each
powered condition and used this as an estimate of instantaneous metabolic cost at each cor-
responding parameter configuration, x¯i. Substituting x¯i for g(pi)>λ in Eq. (2.11), we used
MATLAB’s Optimization Toolbox to determine the τ and y¯1 that resulted in the smallest
sum of squared error between the estimated metabolic measurements, y¯i, and the actual
measurements, yˆi,
min
τ,y¯1
N∑
i=1
(y¯i − yˆi)2. (2.26)
We used all powered condition data for this optimization beginning from the steady state
of the first powered condition.
2.2.6.4 Cost Mapping Analyses and Statistical Testing
For both the ICM and SSCM analyses, we estimated the cost landscape using a third order
polynomial; therefore, we defined the vector of basis functions as
g(p) =
[
1, p, p2, p3
]>
. (2.27)
We used these basis functions in order to be consistent with work presented in [101]. We
considered the 95% confidence region for all confidence band analysis by using a 5% crit-
ical point in calculating F . We computed 105 Monte-Carlo roll-outs in calculating the
p?-probability distribution. We regarded the step exploration with a SSCM analysis as the
current field standard and all reported comparisons are made relative to it. We used a paired
t-test (α = 0.05) for all reported p values.
2.3 Results
From the 8 subjects presented here, we identified subject-specific time constants, τ , of
47.8± 12.4 (mean ± s.d.) seconds. The fitted curve from the standard SSCM protocol
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shows that subjects on average experience a 0.808± 0.184 W kg−1 (19.6± 3.3%) reduc-
tion in metabolic power between the worst case parameter setting and p?. All major results
comparing both explorations with an ICM analysis to the standard SSCM are shown in Fig.
2.6.
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Figure 2.6: Experimental results comparing parameter explorations and analyses against
one another. Experimental results compare the metabolic cost landscapes of both the step and
ramp explorations with an ICM analysis to the standard practice of a step exploration with a SSCM
analysis. The results show that neither protocol had a significant difference in identified p? locations
or standard deviations of the p?-probability distributions when compared to the standard practice
protocol. There was a significant difference in both protocols’ band area when compared to the
standard practice.
2.3.1 Step Exploration with an ICM Analysis
The step exploration with an ICM analysis identified p? configurations that were on average
0.012± 0.024 normalized stride time away from that identified by the standard step explo-
ration with a SSCM analysis. This is an absolute difference of 0.020± 0.017 normalized
stride time. The differences in p? configurations predicted by the two protocols were not
significantly different from zero (p = 0.187).
The confidence analysis shows that the step exploration with an ICM analysis resulted
in an area of the 95% confidence band about x¯(λ?, p) that was 25.1± 3.5% less than that of
the standard SSCM analysis. The differences in the two protocol’s band areas was signifi-
cantly different from zero (p < 0.001). However, when comparing the p?-probability dis-
tributions, there was no significant difference in the mean or standard deviation (p = 0.132
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and p = 0.088, respectively) between the two protocols. The results of this protocol for a
single representative subject are shown in Fig. 2.7.
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Figure 2.7: Comparing a step exploration with a SSCM analysis to a step exploration with
an ICM analysis for a single representative subject. For this representative subject, the step
exploration with an ICM analysis had a confidence band area about x¯(λ?, p) that was 28% less
than that of the step exploration with a SSCM analysis. The p?-probability distribution of the step
exploration with an ICM analysis had a standard deviation 17% less than that of the step exploration
with a SSCM analysis.
2.3.2 Ramp Exploration with an ICM Analysis
The ramp exploration with an ICM analysis identified p? configurations that were on av-
erage 0.016± 0.020 normalized stride time away from that identified by the standard step
exploration with a SSCM analysis. This is an absolute difference of 0.072± 0.065 normal-
ized stride time. The differences in p? configurations predicted by the two protocols were
not significantly different from zero (p = 0.661).
The confidence analysis shows that the ramp exploration with an ICM analysis re-
sulted in an area of the 95% confidence band about x¯(λ?, p) that was 41.2± 31.1% greater
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than that of the standard SSCM analysis. The differences in the two protocol’s band ar-
eas was significantly different from zero (p = 0.005). However, when comparing the p?-
probability distributions, there was no significant difference in the mean or standard devi-
ation (p = 0.350 and p = 0.915, respectively) between the two protocols. The results of
this protocol for a single representative subject are shown in Fig. 2.8.
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Figure 2.8: Comparing a step exploration with a SSCM analysis to a ramp exploration with
an ICM analysis for a single representative subject. For this representative subject, the ramp
exploration with an ICM analysis had a confidence band area about x¯(λ?, p) that was 86% greater
than that of the step exploration with a SSCM analysis. The p?-probability distribution of the
step exploration with an ICM analysis had a standard deviation 159% greater than that of the step
exploration with a SSCM analysis. This is the same representative subject as shown in Fig. 2.7.
2.4 Discussion & Conclusion
We presented a generalized instantaneous cost mapping (ICM) analysis that allows for
the use of steady and non-steady-state measures in estimating metabolic cost landscapes
of any dimensionality or order. Additionally, we derived novel confidence analyses that
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allow for an in-depth evaluation of curve fits and a comparison of mapping protocols on
a subject-specific basis. We demonstrated these techniques by mapping healthy subjects’
metabolic cost landscapes as functions of the actuation onset for pneumatically powered
bilateral ankle exoskeletons. We first showed how an ICM analysis can improve upon a
steady-state cost mapping (SSCM) analysis, the current standard in the field, when using a
step exploration. The results show that an ICM analysis can decrease the 95% confidence
band area about x¯(λ?, p) by 25.1± 3.5% with no significant change in the identified p?
configuration (p = 0.187) when compared to a SSCM analysis of the same parameter
exploration. This significant decrease in band area (p < 0.001) indicates a more confident
fit in an ICM analysis than a SSCM analysis when the same parameter exploration is used
for both. This result is a consequence of the fact that the ICM analysis is able to include
twice as much data as the SSCM analysis. This point illustrates that if the physical shape
and absolute values of x¯(λ?,p) are of importance than it may be worth using an exhaustive
step exploration with an ICM analysis to maximize the amount of data being considered in
a fit.
Knowing that an ICM analysis can be used to include non-steady-state measurements in
estimating a metabolic cost landscape, we then asked the question of “what is the penalty
in estimating a metabolic cost landscape using a much shorter parameter exploration?”
The ramp exploration with an ICM analysis included no steady-state data in the analysis
and required less than half the time to conduct than the standard step exploration with a
SSCM analysis. We found that the p? configurations identified by the ramp exploration
with an ICM analysis were not significantly different from that of the step exploration with
a SSCM analysis (p = 0.661). The p? configurations identified using the ramp explo-
ration with an ICM analysis were on average 0.016± 0.020 normalized stride time away
from that identified by the standard step exploration with a SSCM analysis. This differ-
ence in p? configurations would only result in an average increase of 1.2% in metabolic
power when evaluated using the curve identified by the SSCM analysis. Additionally, there
was no significant difference in p?-probability distribution means or standard deviations
between the ramp exploration with an ICM analysis and that of the step exploration with
a SSCM analysis (p = 0.350 and p = 0.915, respectively). These results suggest that a
shortened parameter exploration with an ICM analysis can identify p? configurations with
no significant difference in accuracy to that of the field’s standard step exploration with a
SSCM analysis. However, there was a significant increase in the 95% confidence band area
about x¯(λ?, p) identified using the ramp exploration with an ICM analysis compared to that
of the step exploration with a SSCM analysis (p = 0.005). This increase in band area of
41.2± 31.1% suggests that a short parameter exploration with an ICM analysis may not
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be best when the overall shape and absolute values of the metabolic cost landscape are of
interest. We would like to emphasize that we are not advocating that the ramp exploration
presented here is the optimal means of traversing a parameter space in order to estimate a
metabolic cost landscape, but it is just one of infinitely many possible continuous explo-
ration patterns. Further investigation is needed to identify what exploration practices are
best when using an ICM analysis. Additionally, the minimum time required for an ICM
protocol to accurately identify a minimizing parameter configuration can vary from device
to device depending on how many parameters need to be tuned and the level of impact
those parameters have on the users’ metabolic power.
A major take away of this work is that we can now consider subject-specific confi-
dence on estimated cost landscapes and minimizing parameter configurations. We believe
these methods play an important role in protocol validation and comparisons as alternative
mapping protocols emerge in the field. In future work we hope to use curve confidence to
better inform autonomous and “smart” explorations of parameter spaces when considering
a multidimensional parameter space. For example, the elements of Σ can directly inform
an algorithm which elements of λ? it is least confident in identifying. Thus, the covariance
matrix can indicate which direction of the parameter space is needed to be further explored
to gain a more accurate estimate of the cost landscape or minimizing parameter config-
uration. This type of information could be very useful for directing ‘Body-in-the-Loop’
optimizations in future work [43, 87].
The methods we have presented here have been formulated in a generalized notation
such that they can be applied to any type of sensor that estimates a physiological measure
so long as the sensor dynamics can be described as a linear equation. Alternative sensors
may take measurements of limb dynamics, heart rate, or electrodermal activity [16,41,107].
Although none of these sensors alone can accurately estimate metabolic power, the com-
bination of many sensors using sensor fusion can potentially improve this estimate [41].
Future work is aimed at developing methods for sensor fusion of these types of measures to
better estimate real-time metabolic power. Furthermore, metabolic power is only a single
objective function to consider when tuning a device. We believe that considering alterna-
tive cost landscapes will be necessary for applying these techniques to clinical populations
where measures other than metabolic power may be of greater concern when tuning a de-
vice. Recent work has shown that users’ perception of their biomechanics, or satisfaction in
a given parameter configuration, does not always correlate with their measured metabolic
power [110]. Measures of user satisfaction can be a combination of measures such as bal-
ance, comfort, stress, or perceived effort. Given that physiological objectives other than
metabolic power contribute to user satisfaction, it may be necessary to consider these ob-
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jectives during the tuning of devices in future work. The investigation of alternative sensors
could allow for these other physiological objectives to be measured and considered as al-
ternative cost landscapes. The sensors associated with these measures need to be more
transparent and less cumbersome than a metabolics mask so they can be used on a daily
basis. We believe the methods laid out here will be a key starting point for this ground
work.
The presented methods are not constrained to control parameters on assistive robotic
devices. A wide variety of experimental biomechanics studies aim to estimate metabolic
cost landscapes as a function of biomechanical manipulations. For example, studies have
looked at the effects of walking speed, walking incline, step frequency, or step width on
metabolic power [39, 40, 63, 104, 133, 150]. These types of studies could greatly benefit
from the techniques we have described here. The curve confidence methods could aid in
the experimental design process by providing more information to the researchers about a
given protocol and would allow for a more quantitative inter-subject analysis. Additionally,
these studies could use ICM techniques to include more data in their analyses if they wish to
improve curve confidence or they could use ICM techniques to significantly reduce testing
time if they wish to only identify experimental parameters that minimize metabolic power.
2.5 Appendix: Proving an Analytic Solution to Solving the
Confidence Band of a Curve
The analytic solution for the confidence band of a curve is the result of solving the extremal
problem
max/min
λ◦
g(p◦)> (λ◦ − λ?)
subject to (λ◦ − λ?)>V(λ◦ − λ?) ≤ 1
. (2.28)
Here we will only solve for the minimization, but the maximization follows a similar proof.
We can solve for the above minimization using a change in variables to simplify the prob-
lem statement. We first assume that Σ is a positive definite matrix (as opposed to positive
semi-definite) since there is guaranteed to be noise in our measurements. If Σ is a positive
definite matrix, V is also a positive definite matrix. Therefore, V has a a positive definite
principal square root, V1/2. Defining z˜ = V1/2(λ◦ − λ?) and g˜ = V−1/2g(p◦), we can
simplify Eq. (2.28) to
min
z˜
g˜>z˜
subject to z˜>z˜ ≤ 1.
(2.29)
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We then can express the Lagrange equation for the above as
L(z˜, α) = g˜>z˜ + α (z˜>z˜ − 1) (2.30)
where α is the Lagrangian multiplier. The partial derivatives of the Lagrange equation are
∂L
∂z˜
= g˜ + 2αz˜
∂L
∂α
= z˜>z˜ − 1.
(2.31)
Setting the partial derivatives equal to zero and solving for z˜ results in
z˜min =
−g˜
||g˜||2 . (2.32)
Substituting for z˜ and g˜, we can solve for the λ◦ that corresponded to the analytic solution
of the confidence band.
λ◦min = λ
? − V
−1g(p◦)√
g(p◦)>V−1g(p◦)
. (2.33)
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CHAPTER 3
‘Body-in-the-Loop’ Optimization of Assistive
Robotic Devices
3.1 Introduction
The control of a typical assistive robotic device relies on mechanically intrinsic mea-
surements. These are measurements that come from the device itself and they are used
to estimate the state of the human-machine system. These state estimates allow for the
controller to determine the user’s intent and the current phase of a given task. With this
information, the controller allows the assistive device to aid the user in a variety of sce-
narios. Examples of mechanically intrinsic measurements include position, velocity, force,
and impedance [6,17,64]. For example, in an upper extremity exoskeleton, force measure-
ments between the user and the device can be used to predict the user’s intended reaching
trajectory [100]. Or in a lower limb prosthesis, acceleration measurements of the device
can be used to estimate what phase of the gait cycle the user is currently in. This same
acceleration measurement can determine if the user is intending to climb stairs or walk on
level ground [79].
While mechanically intrinsic measurements estimate the state of the human-machine
system, physiological measurements such as pain, anxiety, effort, or energy consumption,
are commonly used to evaluate the performance of the device. Conclusions based on these
physiological measurements are then used to alter the design and to modify the shape of
actuation to better assist the user. The process of using physiological measurements to
shape actuation is an iterative, trial-and-error process. The measurements need to be taken
during human subject testing and then analyzed by researchers or clinicians offline after
testing. The results from this analysis are then used to drive future designs of actuation
The content of this chapter has been previously published and presented at Robotics: Science and Systems
2016 [87].
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shape or tuning for a given device. This process is repeated until the desired results are
achieved. For example, in an upper extremity prosthesis, measurements of user pain can be
used to iteratively shape actuation such that users are most comfortable [103]. Or in a lower
limb exoskeleton, measurements of energy consumption can be used to tune parameters
that shape actuation profiles in an attempt to identify parameters that result in the largest
reduction in the user’s metabolic effort [101].
Real-time Estimation of a Physiological 
Objective From Sensory Measurements
S
en
so
r F
us
io
n
}
Application in Assistive Robotics
C
Control
Real-time Optimization of
a Physiological Objective
Online Optimization
Physiological
Objective
p
Optimal Actuation Shape
Actuation
Shape
Shaping Parameters
P
ar
am
et
er
S
et
tin
g
x(p)
p
Figure 3.1: An example of the generalized approach to the Body-in-the-Loop optimization
of assistive robotic devices. Here is an illustration of the proposed concept of Body-in-the-Loop
optimization. While a user is wearing an assistive robotic device (shown are devices that aid loco-
motion), a number of sensor readings are fused to form an estimate of a physiological measure x
(such as pain, anxiety, effort, or energy consumption). This physiological measure is used as the
objective function in an online optimization that identifies optimal controller parameters p. These
targeted controller parameters influence the shape of assistance that is provided by the assistive de-
vice to the user. Additional intrinsic measurements from the device are used to estimate user intent
and phasing of the assistance to drive the output of the controller C. Optimization is done with a
human body in the loop which is a radically new way of human-machine interfacing.
Clearly, both mechanically intrinsic measurements and physiological measurements are
needed for the design and control of assistive robotic devices. However, in the current field
of assistive robotic devices there is a divide between these measurements as they are not
used concurrently in real-time control. We are proposing a new method of human-machine
interfacing, one in which control parameters that shape assistance, p, are optimally tuned
and adjusted in real-time to minimize a physiological objective function from the user,
x (p). By including physiological measurements, y, in the control scheme to estimate
37
x (p) and drive optimization, we are bringing the human body into the control loop. This
Body-in-the-Loop approach has the potential to open up a new realm of assistive robotic
control.
By including quantitative physiological feedback in a real-time optimization of shap-
ing parameters, we can create robotic devices that learn and adapt in order to continuously
provide optimal subject-specific assistance. The optimization process can be performed
during the development of a controller for a new assistive system, as well as every time
a particular device is fitted to a user. This allows adaptation to unique attributes such as
the user’s size, weight, or preferred movements, and it will greatly improve and accelerate
the tedious task of controller tuning. It will substantially enhance the performance of cur-
rent assistive robotic devices by optimally utilizing potential synergies between user and
machine. In the long run, the proposed automated tuning can be applied not only when a
device is built or fitted, but on a continuous basis as the person uses it. For example, in the
case of a lower limb prosthesis, the controller could adapt in real-time to the type of shoes
that the person is wearing, the terrain that is being traversed, or additional loads that a user
might be carrying.
Felt et al. proved such an optimization was possible by optimizing step frequencies
during normal walking of healthy subjects as a proof of concept [43]; however, this type
of optimization has never been demonstrated on an actual assistive device until now. Here
we expand upon Felt’s work by presenting the first ever example of Body-in-the-Loop
optimization driven by objective physiological measurements to optimize the control of
an assistive robotic device. We build upon Felt’s algorithm by including an oscillatory
perturbation pattern, a growing sample window, and statistical confidence checks of each
gradient estimate. All of these additions were crucial for improving the performance of
Body-in-the-Loop optimization when applying these techniques to assistive devices due to
the cost landscape being much shallower compared to that of Felt’s step frequency study.
In this paper we have demonstrated the utility of Body-in-the-Loop techniques for the
optimization of bilateral pneumatically actuated ankle exoskeletons during level ground
walking. These exoskeletons provided additional power to aid in push-off, reducing the
metabolic effort required of the individual. We chose such a platform because devices
targeting assistance at the ankle are commonly used in both a research and clinical set-
ting due to the ankle’s large contribution toward positive power generation during gait
[9, 42, 77, 101]. Our designed exoskeletons were simply controlled by a single shaping pa-
rameter, p, which controlled the actuation onset of the device. p represents a normalized
stride time threshold such that once a user’s phase of normalized stride surpassed p, action
was turned on. This is visualized in Figure 3.4 and has been a common control scheme used
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Figure 3.2: Proposed experiment for Body-in-the-Loop optimization of bilateral robotic ankle
exoskeletons. In a validation study, we optimized the actuation onset (as parameter p) of bilateral
ankle exoskeletons to minimize user’s metabolic effort (as physiological objective x(p)). The ex-
oskeleton controller used normalized stride time between consecutive heel strikes (SHS and S′HS)
as the state estimate to drive actuation. Actuation was turned on when the normalized phase of the
stride S was greater than the parameter setting p and off when toe off (STO) was detected. We
implemented gradient descent optimization techniques to autonomously move toward a setting of p
that minimized x(p). With this robotic device, we validated the Body-in-the-Loop techniques with
eight healthy subjects, using a brute force mapping of subject specific cost landscapes as a ground
truth for comparison.
for basic science research with robotic ankle exoskeletons [24,101]. The Body-in-the-Loop
optimization scheme tuned p using metabolic effort as the physiological objective. We were
able to estimate the user’s metabolic effort in real-time via respiratory measurements us-
ing a mask as shown in Figure 3.3. Through the results from a extensive human subject
study, we have shown that the proposed Body-in-the-Loop optimization techniques can
autonomously move towards a metabolic minimum validating that Body-in-the-Loop opti-
mization has the potential to be an impactful tool for future human-machine interactions.
3.2 A Pneumatically Actuated Robotic Ankle Exoskeleton
We used bilateral, single degree of freedom, pneumatically actuated ankle exoskeletons
as a platform for testing the proposed Body-in-the-Loop optimization. We designed these
exoskeletons based on previous work in the field [44].
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3.2.1 Hardware
Each exoskeleton consisted of a shank and a foot component connected by a rotational joint.
The shank diameter was adjustable via ratcheting straps to fit a variety of subject sizes. The
shoes were customized orthotic shoes that had been outfitted with a stainless steel plate in
the heel. This plate served to stiffen the heel of the shoe and provide attachment points for
the actuators and rotational joints.
Load Cell
Pneumatic Actuator
Metabolics Mask
Air Supply
Split Belt Treadmill
with Force Plates
Adjustment Straps
Rotational Joint
Orthotic Shoe
Shank Cuff
Figure 3.3: Experimental setup for Body-in-the-Loop optimization of bilateral robotic ankle
exoskeletons. The ankle exoskeletons used in this study were pneumatically actuated with cus-
tom built artificial pneumatic muscles attached posteriorly to assist with push off. During testing,
subjects walked on a split belt treadmill with incorporated force plates to register heel strike and
toe off events. Respiratory measurements were recorded in real time with a metabolics mask. The
air pressure in the actuators was regulated with off board proportional pressure control valves (not
shown). Adjustment straps allow fitting the device to different users.
We actuated each exoskeleton with a custom made artificial pneumatic muscle [31]
that had attachment points at the top-rear of the shank and at the back of the heel. The
moment arm between the rotational joint and the actuation attachment point at the heel
was 10.1 cm. The artificial muscle was connected to a proportional pressure control valve
(MAC Valves,Wixom, MI) with a mechanical quick release valve (Parker Legris, Mesa,
AZ) connected in series. Additionally, we attached a load cell (Omega Engineering, Stam-
ford, Connecticut) in series with the artificial muscle to record actuation kinetics. This
actuation configuration had an electromechanical delay of 28 ms. In optimal controller
configurations, this exoskeleton can provide approximately 50% of the torque required at
the ankle during normal walking. Each exoskeleton, artificial pneumatic muscle, and load
cell had a combined weight of 2.02 kg. This weight was slightly larger than other state of
the art exoskeletons in the field, yet it was within the weight range of exoskeletons that have
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previously shown significant reductions in metabolic effort (0.67 - 2.30 kg [101, 106]).
3.2.2 Control
We controlled the exoskeleton using a simple state-based control strategy that has been
presented in previous ankle exoskeleton work [24, 101]. The controller was simply an ‘on-
off’ control scheme that was triggered by a single state, S, crossing a threshold value, p. p is
the shaping parameter that we optimized for during validation testing. S was a measure of
normalized stride time where S = 0 and S = 1 corresponded to consecutive heel strikes of
the same leg. We used vertical ground reaction forces on the treadmill to detect heel strike,
SHS , and toe off, STO, of each stride. We calculated stride times from the time between
consecutive heel strikes of the same leg and then normalized them by an average stride time
to calculate S. We calculated the average stride time using a finite impulse response filter
with a tap size of five.
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Figure 3.4: Controller to be optimized during the Body-in-the-Loop optimization. The control
signal that was sent to the pressure control valves was based upon normalized stride time, S. The
bottom graph shows a single stride of the exoskeleton where SHS = 0, STO ≈ 0.63, and S′HS = 1.
The middle graph shows how actuation is turned on once S ≥ p and off once S ≥ STO. The top
graph shows an example of the expected torque output of the exoskeleton. This profile will change
dependent upon what p is set to and as a function of user specific ankle kinematics during walking.
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When p ≤ S ≤ STO, actuation was turned on. Actuation was turned off otherwise.
When the controller was in the on state, we pressurized the artificial pneumatic muscles
with 600 kPa of pressure and when in the off state with 150 kPa of pressure. The reason
for a non-zero off state pressure was to deplete any dead space in the tubing and muscle.
This allowed for a quicker actuation response and limited electromechanical delay in our
control system. The off pressure of 150 kPa did not result in any inflation of the artificial
pneumatic muscle and thus no tension was registered by the load cells during the off state
due to actuation pressure.
3.3 Metabolic Effort as a Physiological Cost Function
For this study we used metabolic effort as the physiological cost function, x(p), to min-
imize. In relation to metabolic effort, x(p) is also known as the instantaneous energetic
cost [118]. Metabolic effort is a measure of how much energy the human body is expend-
ing during any task and can be estimated from a variety of physiological measurements
such as oxygen consumption, heart rate, oxygen saturation in the blood, or muscle activ-
ity [19,54,71,84]. Most commonly, metabolic effort is estimated from oxygen consumption
via respiratory measurements, y, and is a primary method for evaluation of assistive robotic
devices [38]. In collecting respiratory measurements, subjects wear a mask that samples
the oxygen and carbon dioxide content of each individual breath. Using equations from
Brockway [19] and normalizing by subject mass, we convert these respiratory measure-
ments (mL
sec
) to measurements of energy consumption (W
kg
).
Although respiratory measurements give us a fairly accurate estimate of metabolic ef-
fort, there are significant sensor dynamics that prevent measuring x(p) directly. Respiratory
measurements are ideally meant for long testing trials at steady state conditions due to a
long delay between the instantaneous energetic demand and the physical respiratory mea-
surements. When muscles need instantaneous energy they pull from local energy storage
in the form of adenosine triphosphate (ATP). These local storages of ATP are then replen-
ished through a number of processes that require oxygen pulled from the blood stream. It
takes time for this oxygen depleted blood to travel from the muscle location to the lungs, so
there is a delay between this initial recruitment of energy and the observation of increased
oxygen consumption via respiratory measurements. Because of this delay, the dynamics
of the human metabolic system are commonly modeled as a first order system, having a
time constant τ of approximately 40 seconds during walking [91, 118, 139]. It is common
practice to have subjects walk at a given condition for at least three minutes to allow for
metabolic effort to stabilize prior to collecting measurements for analysis due to this large
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time constant. Additionally, respiratory measurements are very sparse because only one
measurement is made per breath. During normal walking subjects take approximately 19
breaths per minute which results in a sample rate of 0.32 Hz [18]. On top of all that, respi-
ratory measurements are incredibly noisy, having a signal to noise ratio of approximately
four [91, 139]. Given this sparse sample rate and high noise level, it is typical to average
respiratory measurements across multiple minutes to achieve a single data point estimate
of x(p).
Dynamic delay, sparse sampling, and large inter-breath variability all make for using
respiratory measurements to drive an online optimization increasingly difficult. In order
to use this information in a real-time optimization, we need to establish a suitable sensor
model of respiratory measurements. The input to this sensor is the instantaneous energetic
cost x (pi). The output are individual breath measurements of energy consumption yi. i is
the breath number and replaces a notion of time in this discrete breath-by-breath process.
Approximating the metabolic dynamics as a discrete linear first order system, we relate
respiratory measurements, yi, of each breath i, to metabolic effort, x(pi):
yi =
(
1− hi
τ
)
y(i−1) +
hi
τ
x (pi) . (3.1)
In this equation, hi is the time since the previous breath and τ is the time constant of the
metabolic system [43].
3.4 Optimization of Metabolic Effort
Based on this sensor model, we developed an algorithm for the real-time optimization of
metabolic effort. Please note that the figures in this section are representing exemplary data
from a single pilot subject. Data from the complete validation study is presented in Section
3.5.2.
3.4.1 Establishing a Ground Truth
In order to objectively evaluate the proposed Body-in-the-Loop optimization techniques,
we first established a ground truth of the cost landscape. To this end, we mapped subject’s
energetic cost landscapes using a steady state cost mapping (SSCM) protocol similar to
Felt et al. [43]. This SSCM protocol is a type of parameter study common in assistive
robotics to brute force map x(p) [28, 33, 101].
The SSCM protocol that we implemented had subjects standing in place for four min-
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Figure 3.5: Establishing a ground truth cost landscape to compare the optimized results to.
To provide a ground truth for comparison, the cost landscape for each individual subject was found
by averaging the final three minutes of metabolic data from each powered condition during a steady
state cost mapping trial. Each average (shown here for a pilot subject) is represented by a colored
dot and numbered according to the testing sequence. The subject’s standing metabolic power has
been subtracted from all shown values. A third order polynomial was fit to these steady state values
(shown in yellow). For comparison, the dashed line shows the subject’s metabolic power when
walking in the unpowered exoskeletons. The highest parameter setting was repeated three times (1,
5, 9) to test for learning and fatigue effects.
utes to measure their standing metabolic effort. We then had subjects walk with the ex-
oskeleton in an unpowered condition followed by nine powered conditions. Subjects walked
for six minutes in each condition. This process was performed continuously where subjects
were only given verbal warnings before starting the treadmill, powering on the exoskele-
tons, and powering off the exoskeletons. Subjects walked at seven different powered pa-
rameter settings (p = 0.13, 0.21, 0.28, 0.36, 0.43, 0.51, and 0.58) for nine different powered
conditions. The first, fifth, and ninth powered conditions were always p = 0.58. All in-
termediate powered conditions were randomized. The repeated p = 0.58 allowed us to
analyze learning effects and fatigue in subjects. If we saw significant differences in the
first, fifth, and ninth parameter’s steady state values, we could assume that the subject was
still learning and adapting to the device, or that they were becoming fatigued. We chose
the parameter of p = 0.58 for this repetition, because this setting turns actuation on for
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the shortest amount of time. Since STO ≈ 0.63 [101], the device was only powered for
∼60 ms at this setting. By starting and ending with this parameter setting, we were able to
ease subjects in and out of powered conditions in the smoothest and safest way possible.
After data collection, we averaged the final three minutes of data from each powered
condition in the SSCM data set to generate an estimate of the instantaneous energetic cost,
x¯ (p). In the realm of assistive devices, it is common practice to estimate x¯ (p) with a third
order polynomial fit [33, 65, 101]. This representation of x¯ (p) versus p is shown in Figure
3.5.
3.4.2 Online Optimization
Algorithm: Body-in-the-Loop Optimization
Data: Respiratory measurements of metabolic power, yˆ
Result: Minimizing x(p)
Initialize:
f = 0
n0 = 0
n1 = initial number of respiratory measurements to evaluate
p1 = initial guess of the optimal p
while t < tend do
for i = (nf + 1) : nf+1 do
pi =

pk − (−1)fc i ≤ nf+1+2nf
3
pk + (−1)fc i > 2nf+1+nf
3
pk otherwise
Collect corresponding yˆi
Calculate best linear fit, x¯
(
λ?(1), p
)
, from measurements i = 1 : nf+1
Compute Akaike weight, w1
if w1 > wthresh then
Set f = 0
pk+1 = pk − αk∇x¯ (λ?(1), p)
else
Set f = f + 1
Define nf+1 = n1(1 + δf) + nf
Our proposed online optimization scheme is based upon gradient descent methods [13].
We allowed the algorithm to run for a set amount of time (tend) during which it was fully
autonomous meaning there was no human intervention once the algorithm had begun. An
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overview of our algorithm is presented above as pseudo-code with the variables defined in
the proceeding subsections.
3.4.2.1 Parameter Exploration about pk
To obtain an estimate of the gradient of the physiological objective at pk, we systematically
explored parameter settings surrounding pk. We did this by initially evaluating below, at,
and above pk for a total of n1 breaths. If we were not confident in the gradient estimate of
pk after n1 breaths (ie it failed a statistical test of confidence) more data was collected. In
these additional evaluations we collected data about pk in the reverse order of the previous
exploration for a total of n1 (1 + δf) more breaths. The variable f counted the number
of evaluations, and a larger number of breaths was collected in each subsequent evalua-
tion. We reevaluated the gradient for all measurements collected about pk and repeated as
necessary.
This oscillatory sampling pattern about pk was defined as follows such that nf and nf+1
were breath numbers, i was the breath count at pk, c was the perturbation size, and f was
the number of failed statistical tests at pk.
pi =

pk − (−1)fc i ≤ nf+1+2nf
3
pk + (−1)fc i > 2nf+1+nf
3
pk otherwise
(3.2)
We initialized n0, n1, f , and p1 before the algorithm began. n1 was a user defined input for
the initial number of respiratory measurements to consider per oscillation and p1 was an
initial guess of the optimal p location. If the gradient fit failed a statistical test of confidence
then we incremented f and calculated nf+1 as
nf+1 = n1 (1 + δf) + nf (3.3)
where δ represents a user defined growth factor.
3.4.2.2 Gradient Estimate
Based on the measurements yi at the known parameter settings pi, we estimated a linear
representation of x(p) and extracted the gradient from this representation. This linear rep-
resentation was defined by a set of coefficients λ.
x¯
(
λ(1), p
)
= λ0 + λ1p (3.4)
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In this notation, the gradient of the linear function, ∇x¯(λ(1), p), is simply λ1. By running
this linear approximation through Eq. (3.1), we produce an estimate of metabolic effort y¯i
as a function of λ and pi:
y¯i =
(
1− hi
τ
)
y¯(i−1) +
hi
τ
x¯
(
λ(1), pi
)
. (3.5)
Starting from an initial value y¯1, the series of estimated breath measurements y¯i can be
obtained by recursively evaluating Eq. (3.5). The resulting expression is linear with respect
to a y¯1 and λ: 
y¯1
...
y¯n
 = A
y¯1λ0
λ1
 . (3.6)
A is a n × 3 matrix whose elements are calculated recursively based upon τ , hi, and
pi [43].
Ai,j=

1 i = 1, j = 1
0 i = 1, j > 1
Ai−1,j
(
1− hi
τ
)
i > 1, j = 1
Ai−1,j
(
1− hi
τ
)
+ hi
τ
∂x¯(λ(1),pi)
∂λj−2
i > 1, j > 1
(3.7)
For a given set of breath measurements yˆi, we employ the pseudo-inverse of A (denoted
as A+) to solve for the optimal initial breath, y¯?1 , and optimal linear fit, λ
?
(1), that yield a
least-square fit between yˆi and y¯i: y¯
?
1
λ?0
λ?1
 = A+

yˆ1
...
yˆn
 . (3.8)
That is, we identified model coefficients that provide a best fit between the linear model
x¯(λ(1), p) and the true underlying relationship x(p). Through this process, a new gradient
∇x¯(λ(1), p) was established every time a total of nf+1 measurements had been taken about
pk.
In addition to fitting a linear model (as per Eq. (3.8)), we used the same process to
simultaneously identify a purely constant (zeroth order) model, x¯(λ?(0), p):
x¯
(
λ(0), p
)
= λ0. (3.9)
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We used this model to evaluate confidence in the gradient fit. In this model A was a n × 2
matrix.
3.4.2.3 Confidence in the Gradient
Due to the poor signal to noise ratio of respiratory measurements, we implemented a sta-
tistical test to evaluate how confident we were in any given linear fit prior to acting upon
it in the gradient descent algorithm. To this end, we compared the optimal first order fit
to data about pk to the optimal zeroth order fit to the same data. If the first order fit was
statistically better at describing the data than the zeroth order fit (that is, when a gradient
fit the data better than a flat line) the gradient was used to update pk. The implemented
statistical test used Akaike weights and a user defined threshold to establish confidence in a
gradient estimate. From simulations of the Body-in-the-Loop optimization, we found this
method to be more conservative in nature compared to other statistical tests.
The Akaike Information Criterion, AICl, is a measure used when comparing model l to
multiple other model fits and is meant to determine which model in a given set is the best
fit [2, 22]. In this framework, AICl can be calculated as
AICl = nf+1 ln
(
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nf+1
)
+ 2 (m+ 1) . (3.10)
where e is the sum of squared error between y¯ and yˆ (defined in Eq. (3.14)), and m is the
number of elements of λ. By traditional standards, the lowest AICl value from the set of
models, min AIC, is the best model fit of the group; however, the min AIC value alone does
not give a sense as to how much better the best fit truly is. We used Akaike weights, wl,
to give us a sense of confidence in the model fits. wl can range from 0 to 1 and can be
interpreted as the probability that model l is the best model within a group of R total model
fits [22, 23]. wl is defined as
wl =
exp {−0.5∆l}
R∑
r=1
exp {−0.5∆r}
(3.11)
where ∆l = AICl −min AIC.
In the described optimization scheme we used the Akaike weights to compare a first
order fit, x¯(λ?(1), p), to a zeroth order fit, x¯(λ
?
(0), p), meaning R = 2 in Eq. (3.11). Only if
the Akaike weight associated with x¯(λ?(1), p), w1, was greater than a user defined threshold,
wthresh, the gradient descent algorithm took a step. Otherwise, more data was collected at
the current parameter setting pk.
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3.4.2.4 Updating pk
If w1 > wthresh then the evaluation parameter was updated as
pk+1 = pk − αk∇x¯ (λ?(1).p) . (3.12)
In this equation, αk is a scheduling gain [13, 43] defined as
αk =
A0α0
A0 + kγ
. (3.13)
where α0, A0, and γ are user defined constants with γ = (0, 1]. k was only incremented
if a step was taken at which point f was set to zero. If w1 ≤ wthresh, then no step was taken
and f was incremented while k remained constant.
3.4.3 Implementation
The presented optimization algorithm was implemented in Python. The Python scripts took
in measures of yˆi and communicated pi values via serial connection to a real-time control
board (dSPACE, Inc., Northville, MI) that ran the control loop described in Section 3.2.2.
This real-time control board also received measures of vertical ground reaction force from
the instrumented treadmill and determined instances of heel strike or toe off. Based on these
gait events, the controller calculated appropriate actuation control signals and sent them
to the pressure valves. The valves regulated the pressurized artificial pneumatic muscles
proportional to the received control signals. A list of parameter values used during actual
data collection can be found in Table 3.1. We chose these values based upon simulation
results of the optimization routine. These simulations assumed a Gaussian distribution
in respiratory measurement noise, an average metabolic time constant, and a hypothetical
physiological objective function. For safety reasons, we bound pk between 0.21 and 0.50
in implementation, yet these limits were never needed to be enforced during actual subject
testing.
An important parameter in the algorithm is the time constant τ of the metabolic dy-
namics. There are a number of ways to estimate τ , and it was shown in prior work that
it could simply be approximated by a constant value of 40 seconds [43]. For this work,
we chose to use the SSCM data to estimate subject specific estimates of τ as this data was
readily available. We averaged the final three minutes of each powered condition to estab-
lish a breath dependent estimate of the instantaneous metabolic cost, x¯ (pi). Using x¯ (pi)
and Eq. (3.1), we estimated metabolic cost for a given τ and y¯1. Constraining τ and y¯1 to
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Table 3.1: Variables used in the Body-in-the-Loop optimization
Variable Definition Units Value
tend Termination Time Minutes 50
c Perturbation Size - 0.08
n1 Initial Breath Evaluation Size Breaths 90
p1 Initial Evaluation Parameter - Randomized
δ Evaluation Growth Factor - 0.5
wthresh Akaike Weight Threshold - 0.7
A0 Gain Scheduling Parameter - 1
α0 Gain Scheduling Parameter 1Wkg−1 500
γ Gain Scheduling Parameter - 0.75
positive values, we used MATLAB’s Optimization Toolbox (The MathWorks, Inc., Natick,
MA) to determine the τ and y¯1 that resulted in the smallest sum of squared error between
actual metabolic measurements, yˆi, and estimated metabolic measurements, y¯i. That is to
say,
min
τ ,y¯1
e =
n∑
i=1
(yˆi − y¯i)2 . (3.14)
We only used powered condition data for this fit beginning from the steady state of the first
parameter as shown in Figure 3.6. An example of the optimization being performed with
this subject specific τ and the variable values presented in Table 3.1 is shown in Figure 3.7.
3.5 Experimental Evaluation
To validate the Body-in-the-Loop optimization techniques, we tested the presented algo-
rithm on healthy subjects wearing the bilateral ankle exoskeletons described in Section 3.2.
All testing was in accordance to the University of Michigan’s Medical School’s Institu-
tional Review Board (HUM00070022), and all subjects gave informed written consent to
participate in the study prior to testing.
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Figure 3.6: Fitting subject specific τ values. We used the SSCM data to estimate subject specific
τ ’s. The raw metabolic data (yˆi) is shown in blue, the instantaneous metabolic cost (x¯ (pi)) is
shown in yellow, and the metabolic estimate (y¯i) is shown in orange. During the SSCM we recorded
standing metabolics from the subject for four minutes (S), unpowered walking in the device for six
minutes (UP), and nine different powered conditions for six minutes each (P1-P9). The data shown
here is from a pilot subject that had a metabolic time constant of 36.6 seconds. This graph also
illustrates the sparse data and high noise levels that are typical for respiratory measurements.
3.5.1 Experimental Protocol
We tested the proposed optimization techniques on nine healthy participants. Of these nine
participants, four had never walked in a powered exoskeleton before. Only male partici-
pants were tested due to the large shoe size requirement of the exoskeleton design. One
subject (Subject 2) was deemed an outlier due to inexplicably noisy respiratory measure-
ments (a signal to noise ratio∼2). The eight remaining subjects presented here (age: 23±6
years; body mass: 72.2± 5.3 kg; height: 179.4± 7.7 cm; mean ± SD) walked in bilateral
robotic ankle exoskeletons during three separate testing days.
On the first two days of testing, we performed the SSCM protocol explained in Section
3.4.1 to establish subject specific ground truths. Day one was used as a training day for
subjects to learn and adapt to walking in the device. The data from day one has therefore
been disregarded in this analysis. We used the SSCM data from the second day to estab-
lish a ground truth and to estimate subjects’ time constants τ . All differences in steady
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state metabolic measurements of the repeated first, fifth, and ninth parameters were within
the expected levels of measurement noise. On the third day of testing, we tested the pro-
posed optimization scheme on each subject starting from a randomized start position, p1.
The optimization algorithm was run for 50 minutes before terminating. All walking took
place on a split belt treadmill (Bertec Corporation,Columbus, OH) at 1.2 ms−1 and all mea-
surements of metabolic effort were taken using a portable open-circuit indirect spirometry
system (CareFusion Oxycon Mobile, Hoechberg, Germany).
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Figure 3.7: A single representative subject’s optimization trial with the gradient descent al-
gorithm. Here is an example of a gradient based online optimization run that was started from
p = 0.45. The presented data is from the same pilot subject as the data in Figures 3.5 and 3.6.
Gradient estimates darken to represent progress through the optimization routine. The gradients
are overlaid on the ground truth for visualization purposes. w1 values that correspond to the con-
fidence in a gradient estimate are written touching their corresponding fits with green representing
w1 > wthresh and red representing w1 ≤ wthresh. In this particular case the optimizer finished at
p = 0.28 where the minimum identified from the SSCM was p = 0.23. According to the SSCM
polynomial fit, this error resulted in an increase of 0.023 W kg−1 in metabolic power for this pilot
subject.
3.5.2 Results
Table 3.2 shows the average results from all eight subjects. On average our optimization
techniques terminated at a parameter setting 0.097 away from the optimal parameter setting
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identified from the SSCM protocol. According to the established subject specific ground
truth curves, this parameter error would result in an average increase of 0.056 W kg−1 in
metabolic power. This increase is well within the range of sensor noise for respiratory
measurements. However, to put this increase of 0.056 W kg−1 into perspective, subjects
experienced a 0.80 ± 0.18 W kg−1 (mean±SD) decrease in metabolic power between the
maximum and minimum values of the established ground truth curves. This accounts for
an average reduction of 19.6±3.2%. In comparison, the parameters found by the optimizer
resulted in an average reduction of 18.0 ± 4.6% in accordance to the established ground
truth curves.
Table 3.2: Average results from the Body-in-the-Loop optimization
Mean Standard Deviation
Time Constant τ (Seconds) 47.8 ±12.4
Absolute Error in Minimum p (Unitless) 0.097 ±0.077
3.6 Discussion & Conclusion
The experimental work presented in this paper shows that Body-in-the-Loop optimization
can be a viable tool in the development and tuning of controllers for assistive robotic de-
vices. For all subjects, the presented algorithm was able to autonomously minimize a
physiological objective function in real-time. The key novelty in this context was that
the optimization was based on physiological measurements of human effort. These are
measurements that provided direct and objective feedback about the performance of the
assistive device. From the perspective of a roboticist, this is a radically new way of human-
robot-interaction. This interaction was neither based on a physical exchange between the
robot and the user through forces and velocities (which are, however, used in the controller
of the exoskeleton) nor was it based on the exchange of information through a designated
user interface or a neuro-interface. Instead, the proposed methods allowed a robot to di-
rectly react to the physiological state of the user, a state which may not always be obvious
or may not even be consciously known to the users themselves. With the development of
more unobtrusive sensing technologies, such as skin conductance, heart rate, oxygen sat-
uration, etc., this will allow a continuous and seamless adaptation of robots to their users.
While the methods presented in this paper have focused on metabolic effort as the objec-
tive function, other physiological states might prove interesting candidates for optimization.
This includes pain, comfort, training effort, and others. Of course, there is an even greater
challenge of quantifying these states than of measuring metabolic effort.
53
Additionally, the proposed Body-in-the-Loop optimization techniques allow for param-
eter exploration of actuation shapes that may not be considered using traditional shaping
methods. Currently, researchers shape actuation profiles of assistive devices to match ac-
tuation profiles of healthy, unassisted joints [61]. However, it has been shown that when
using an adaptive controller, subjects may drive the controller adaptation to use abnor-
mal actuation profiles that still appear to minimize a physiological objective [89]. Due to
the inherent parameter exploration of optimization, Body-in-the-Loop optimization could
potentially find optimal actuation shapes that may be disregarded by traditional shaping
methods because they do not resemble healthy joint actuation profiles.
We fully acknowledge that at this stage, the presented concept of Body-in-the-Loop
optimization is still limited. For one, the model we used to estimate metabolic effort com-
bines any time constants associated with learning effects with the estimated time constant
of the subject’s metabolic system, τ . For this initial study we felt that modeling learning
effects would over complicate the methodology, so we attempted to wash out any learning
effects by training subjects on the assistive devices for an adequate amount of time prior to
data collection (day one of testing) [52]. Also, at this point the proposed sensor choice to
estimate the physiological objective of metabolic effort from respiratory measurements is
not practical for daily use outside of the lab setting. For Body-in-the-Loop optimization to
be applicable for continuous use on assistive robotics, more discrete and transparent sen-
sors and estimation methods need to be developed. Furthermore, we assessed the metabolic
effort under deterministic conditions, being that subjects were walking with constant speed
and on level ground. This ensured that changes in metabolic effort were strictly related to
changes in the timing parameter. For the proposed methods to work outside the laboratory,
we will have to extend the algorithms to control for any changes in the subjects locomotion
pattern that might influence the physiological cost function. Such disturbances (such as
varying walking speed or ground slope) must be either detected and compensated for, or
data must be averaged over longer periods of time. Lastly, the devices used in this study are
not an accurate representation of the current state of the art in ankle exoskeletons [101,106].
Our devices were tethered to an air supply which constrained them to only being used in a
lab setting. Also, these exoskeletons were bulkier and heavier than the current state of the
art, resulting in a larger increase in metabolic effort when comparing unpowered walking
in the exoskeletons to walking with no exoskeletons at all. From pilot data, we saw that
our exoskeleton design can reduce metabolic effort slightly below that of walking without
the device when at an optimal parameter setting, yet this reduction was small. However,
these exoskeletons were solely meant to perform as a platform to test the Body-in-the-Loop
optimization techniques on and they greatly served that purpose.
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Though we have validated that Body-in-the-Loop optimization is a viable option for
the control of assistive robotic devices, we have only scratched the surface on the possi-
ble applications. We plan to expand upon the presented techniques to include alternative
physiological objectives and sensing techniques to allow for discrete and continuous opti-
mization during daily routines. Additionally, we plan to expand the techniques to include
multidimensional optimization as most assistive devices can have upwards of ten shaping
parameters [1]. This expansion into multidimensional space could have major implications
to the field as the time required for brute force mapping of physiological objective functions
grows exponentially with increased dimensionality.
55
CHAPTER 4
An Adaptive Gain Proportional Myoelectric
Controller for a Robotic Ankle Exoskeleton
4.1 Background
In order to achieve optimal assistance, the controller of an active prosthetic or orthotic
device must accomplish three tasks. It must reliably determine the user’s intent, precisely
coordinate the timing of assistance with the user, and provide actuation profiles of a suitable
shape. Only if the controller succeeds in all three tasks, the robotic device can achieve its
assistive goal. For example, many robotic assistive devices aim to minimize the energetic
cost for the user to perform a given task. Any amount of error in the controller’s intent
recognition, timing, or actuation shape can result in motion that is energetically costly,
unnatural, or potentially dangerous for the user [38].
Without direct access to the human nervous system, many lower-limb assistive robotic
devices detect intent and timing from estimates of the user’s motion. These measurements
are called mechanically intrinsic as they are taken from the mechanical device itself. These
measurements are used to estimate intent and trigger the timing of predefined actuation pro-
files whose shapes correspond to estimates of intended motion [79]. Controllers that rely
on mechanically intrinsic measurements often use joint angles, impedances, gait events,
or force measurements from the device to control actuation [10, 17, 69, 82, 97]. Recent ex-
oskeleton controller designs relying on this type of sensing have shown promise in reducing
the user’s metabolic cost during walking [101, 106]. However, using mechanically intrin-
sic measurements for control has fundamental limitations. Because mechanically intrin-
sic measurements are outcomes of physical motion, they are prone to mechanical delays.
The desired movement has already started by the time the controller senses it. This delay
The content of this chapter has been previously published in the Journal of NeuroEngineering and Reha-
bilitation [89].
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can cause the control timing to lag behind the user and result in the user fighting the de-
vice [47]. Furthermore, the measurements are subject to complex interactions between the
user’s musculoskeletal system and the mechanical structure of the device. If the combined
human-machine dynamics are not well understood it can be difficult to reliably estimate in-
tent. Additionally, it is impossible for the user to receive appropriate assistance for motion
outside of the controller’s intent laws since all actuation profile shapes are predefined for
specific movements.
The drawbacks of relying on mechanically intrinsic measurements can potentially be
overcome by a direct access to the user’s nervous system. One approach using bioelectrical
signals for control is proportional myoelectric control. A proportional myoelectric con-
troller sends a control signal to the actuators that is proportional to the muscle recruitment
of the user [46,68]. In these controllers muscle recruitment is measured using electromyo-
graphy (EMG). The controller makes no assumptions about the human-machine dynamics
because the measurements used to determine intent come straight from the user instead
of the device. This puts the user in direct control of the exoskeleton and allows for in-
tent recognition to be accurate and consistent. Additionally, proportional myoelectric con-
trol has the potential for zero lag in timing behind the user due to the electromechanical
delay of EMG [30]. EMG signals are produced before muscle tension develops which
allows a proportional myoelectric controller to have a buffer of time between sensor mea-
surement and actuation. The control signal shape of these controllers is proportional to
the user’s EMG signal meaning there is inherent human-machine synchronization. Addi-
tionally, this proportionality implies that the device is not limited to predefined actuation
profiles. Our research group has shown that proportional myoelectric control is a viable
control method for lower-limb robotic exoskeletons that produces a relatively natural and
economical gait [59, 60, 80, 81, 86, 116].
A proportional myoelectric control scheme can be illustrated as follows and is graph-
ically represented by Figure 4.1. Suppose XTot represents the total actuator activation at
the assisted joint including both biological muscles and the exoskeleton’s mechanical actu-
ators. When walking in an exoskeleton, we can apportion the activity from the biological
joint as XBio and the activity from the exoskeleton as XExo. The biological activity can be
thought of as muscle activity about the assisted joint measured via EMG and the exoskele-
ton activity can be thought of as the control signals being sent to the exoskeleton actuators.
XTot = XBio + XExo (4.1)
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Figure 4.1: Graphical representation of total ankle activity contributions with a proportional
myoelectric controller. The above figure is a graphical representation to compliment the math-
ematical theory that describes proportional myoelectric control. In all of the bar graphs, XTot is
represented by the summation of XBio and XExo.
In a proportional myoelectric controller, the activity from the exoskeleton is propor-
tional to the biological activity by some gain β. β maps biological activity to exoskeleton
activity. This mapping is scaled by the ratio c = X̂Exo/XBio, where X̂Exo is the maximum
unsaturated exoskeleton activity and XBio is the normal unassisted joint activity.
XExo = β
(
X̂Exo
XBio
)
XBio = β · c ·XBio (4.2)
The exoskeletons presented here and in our previous research can provide about half the
power of the normal unassisted joint, so c has been estimated as c ≈ 0.5 [59, 116].
In the past, the proportional myoelectric controllers developed by our group created
a control signal for actuation by using a constant gain of β = 2 to map the EMG linear
envelope to an actuation voltage. This gain was chosen with the assumption that during
powered walking total joint activity should be equal to the unassisted joint activity: XTot =
XBio. Additionally, this gain was meant to allow maximal assistance (XExo = X̂Exo)
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during steady state operation. With this, we got from Equation Eq. (4.1):
XBio = XBio + X̂Exo = XBio + XBio · c, (4.3)
and thus a reduction in biological joint activity: XBio = (1− c) XBio. For XExo = X̂Exo,
we can solve Equation Eq. (4.2) for the necessary β:
β =
XBio
XBio
=
1
1− c =
1
1− 0.5 = 2. (4.4)
In previous work, this choice of β resulted in large reductions in metabolic cost. Our
studies have also shown that subjects indeed attempted to adapt to XBio ≈ 1βXBio, in
accordance with Equation Eq. (4.4) [116].
Yet walking in an exoskeleton is different than unassisted walking and we might prefer
more or less total joint activity than XBio. In these previous studies, subjects had the
ability to adapt XBio < 1βXBio and deliberately chose not to. This result suggests that
XTot < XBio is not energetically economical since we generally adapt to move with as
little energy as possible [3,39,48,126,133]. However, subjects were somehow constrained
when attempting XBio > 1βXBio as they would saturate the exoskeleton. Previous work has
shown that subjects avoided this saturation limit, but we do not know the exact reason why.
Perhaps subjects avoided saturation due to discomfort or possibly they chose to avoid the
increased cognitive complexity that comes with learning a highly nonlinear task. Whatever
the reason, we know that subjects naturally chose to avoid operating the exoskeleton within
the saturation range. From Equation Eq. (4.2) it follows that
XExo = β
(
X̂Exo
XBio
)
XBio > X̂Exo, for XBio >
1
β
XBio, (4.5)
so it is unclear whether XTot = XBio is truly the optimal value, or if subjects would prefer
a larger XTot if saturation were avoidable.
Therefore, we saw the need for a proportional myoelectric controller that allows users
to explore higher magnitudes of total joint activity. Such a controller would allow users
to adapt to find the most energetically economical gait on their own. This adapation could
potentially answer whether or not XBio is the energetically optimal total joint activity for
walking in an exoskeleton. In designing such a proportional myoelectric controller, we
wanted to keep the exoskeleton performing at maximum potential regardless of biological
activity (i.e., XExo = X̂Exo). This design would allow for the user to vary the total joint
activity by just varying their biological activity. We made this possible by designing a
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proportional myoelectric controller in which the gain was free to dynamically adapt on a
stride by stride basis. In other words, β was no longer held constant but adapted itself
on each stride i to maintain maximal exoskeleton output. If we set XExo = X̂Exo in
Equation Eq. (4.2), we can express βi as follows:
βi =
XBio
XBio,i
. (4.6)
Combining Equations Eq. (4.1), Eq. (4.2), and Eq. (4.6) shows that this adaptive propor-
tional myoelectric controller could allow users to vary their amount of total joint activity:
XTot =
XBio
βi
+ X̂Exo. (4.7)
It is notable that lower gains βi (a consequence of larger XBio,i) result in larger values for
XTot. A time series representation of this controller dynamically adapting to the user is
shown in Additional file 1: Figure A1 of [89].
The purpose of this study was to to test the performance of an adaptive proportional
myoelectric controller on a robotic ankle exoskeleton. This controller allowed users to
explore a greater possible parameter space of walking in an exoskeleton compared to walk-
ing with traditional proportional myoelectric controllers. We were interested in what β
gain user’s choose when provided an adaptive controller. We tested young healthy subjects
walking with the adaptive gain proportional myoelectric controller on bilateral robotic an-
kle exoskeletons. We predicted that the adaptive controller would allow users to walk with
reduced energetic cost and a β gain less than that of our previous work with a constant gain
controller. A β gain less than that of our previous work would indicate that subjects have
adapted to using more total ankle activity than that of unassisted walking.
4.2 Methods
4.2.1 Subjects
We tested eight healthy subjects for this study (male, 21 ± 1 years, 74.0 ± 2.7 kg, 180.0 ±
2.8 cm; means ± s.e.m.). All subjects were prescreened for exoskeleton hardware fit prior
to testing. Subjects exhibited no gait abnormalities and had no prior experience walking
in a powered exoskeleton. Prior to testing, all subjects gave informed written consent to
participate in the study in accordance to the University of Michigan’s Medical School’s
Institutional Review Board (HUM00070022).
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Figure 4.2: Testing protocol and the adaptive proportional myoelectric controller. (A) All
eight subjects walked at 1.2 ms-1 with the exoskeletons on during three separate training sessions.
Each session consisted of 50 minutes of walking where the first 10 minutes were unpowered, the
following 30 minutes were powered, and the last 10 minutes were unpowered. Four time intervals
from each session were analyzed in the analysis: minutes 7-10 of the 1st unpowered section, minutes
3-6 of the powered section, minutes 27-30 of the powered session, and minutes 7-10 of the 2nd
unpowered section. (B) For control we processed the soleus linear envelope in real time and then
conducted a maximum search on a stride by stride basis. We used these max values to calculate the
mapping gain that the linear envelope was multiplied by to create the actuation control signal.
4.2.2 Exoskeleton Hardware
We custom fabricated bilateral ankle exoskeletons for this study similar to those used in
previous studies from our research group [44,45,59,116]. The exoskeletons consisted of a
shank component and a shoe component that were joined by a rotational joint. This joint
constrained the exoskeleton motion to plantar flexion and dorsiflexion. The shank was
made from stainless steel rods and plastic cuffs. The shoe was a standard orthotic shoe that
was outfitted with attachments for actuation. The exoskeleton could accommodate subjects
that wore between a 9 and 11 U.S. men’s shoe size.
We actuated the exoskeletons using custom built artificial pneumatic muscles attached
posteriorly allowing for plantar flexion assistance when actuated [44]. We attached a load
cell in series (Omega Engineering, Stamford, Connecticut) with the actuator to record ac-
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tuation kinetics. The shoe, shank, actuator, and load cell combined to a total mass of 2.08
kg (approximately 0.81 kg at the foot and 1.27 kg at the shank).
4.2.3 Exoskeleton Control
The exoskeleton controller was a dynamically adaptive proportional myoelectric controller.
We used the wearer’s soleus EMG for the input signal to the controller in order to maintain
biological synergy with the exoskeleton.
We designed the controller to process the user’s raw soelus EMG into its linear envelope
in real time. The processing consisted of a high-pass filter (2nd order Butterworth, cutoff
frequency 80 Hz) to remove motion artifacts, followed by full wave rectification. We then
low-pass filtered the rectified signal (2nd order Butterworth, cutoff frequency 4 Hz) to get
the linear envelope. In a traditional proportional myoelectric controller, this linear envelope
would then be multiplied by a static mapping gain to calculate the control signal [46, 68].
In the current study, this mapping gain was dynamically adjusted by the controller using
the following methodology (Figure 4.2B).
For each stride i, we determined the maximum voltage of the linear envelope, xi, in
real time. We then calculated the gain, gi, necessary for this value to reach a desired peak
actuation voltage, Vpeak.
gi =
Vpeak
xi
(4.8)
We calculated the dynamic gain, Gi, using a finite impulse response (FIR) filter with a tap
size, N = 50, and unity weighting. Gi was then used to proportionally scale the EMG
linear envelope to the actuation control signals.
Gi =
1
N
(
i−1∑
j=i−N
gj
)
(4.9)
The actuation control signals were sent to proportional pressure control valves (MAC
Valves, Wixom, MI). These valves regulated the pressure in the artificial pneumatic mus-
cles to be proportional to the user’s amplified linear envelope. This pressure roughly cor-
responded to the exoskeleton torque output with some nonlinearities induced by actuator
dynamics and a changing moment arm. We ran our controller on a desktop and real-time
control board (dSPACE, Inc., Northville, MI) during all testing. All software was com-
posed in Simulink (The Mathworks, Inc., Natick, MA) and then converted to ControlDesk
(dSPACE, Inc., Northville, MI) using commercial dSPACE software.
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4.2.4 Testing Protocol
The following protocol is largely adapted from [116]. All subjects participated in three
identical training sessions with the device (sessions 1-3). We conducted these training ses-
sions over the course of 7-14 days for each subject, allowing at least one day rest between
sessions for motor consolidation [59, 121]. Each training session consisted of 50 contin-
uous minutes of level ground walking in the exoskeleton. Subjects walked on a split belt
treadmill at 1.2 ms-1 (Bertec Corporation, Columbus, OH) for all tests. The first 10 min-
utes of each walking session were with the device unpowered (i.e., no actuation). We gave
subjects a verbal warning before actuation was turned on for the following 30 minutes.
The FIR filter was initialized with zeros, so a peak control signal was not reached until
50 strides or approximately 60 seconds of powered walking. After the full 30 minutes of
powered walking, we gave subjects a verbal warning before actuation was turned off for
another 10 minutes.
We analyzed data from four time windows of each session: minutes 7-10 of the 1st
unpowered condition, minutes 3-6 of the powered condition, minutes 27-30 of the powered
condition, and minutes 7-10 of the 2nd unpowered condition (Figure 4.2A). Respiratory
data was averaged over each three minute time window. Gait data was avaeraged over the
last 25 strides of each time window. From this gait data, we calculated muscle recruitment,
inverse kinematics, inverse dynamics, and exoskeleton mechanics. Strides were defined
as heel-strike (0% gait cycle) to heel-strike (100% gait cycle). Data from all session’s 1st
unpowered condition were averaged to get the Average Unpowered values. These values
are compared to data from the end of powered conditions of each session in Figures 4.4
through 4.8.
4.2.5 Metabolic Cost
We used a portable open-circuit indirect spirometry system (CareFusion Oxycon Mobile,
Hoechberg, Germany) to measure O2 and CO2 flow rates. We used formulas from Brock-
way [19] to convert these measurements to metabolic power. Prior to walking trials, we
recorded a three minute standing trial from each subject. We averaged over these three
minutes to get each subject’s standing metabolic power which was then subtracted from
each walking trial to calculate the net metabolic power of each walking condition [63]. We
analyzed each walking condition by averaging the metabolic power over a three minute
interval then normalizing it by the subjects body mass. During testing, we monitored each
subject’s respiratory exchange ratio (RER) to ensure that it remained in the aerobic range
(RER<1) [20].
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4.2.6 Electromyography
We measured electromyography from the soleus, tibialis anterior, medial gastrocnemius,
biceps femoris long head, vastus lateralis, and rectus femoris. All EMG recordings came
from the subject’s right side except for the soleus in which recordings came from both the
left and right since they were used as control inputs. We used bipolar surface electrodes
(sample rate: 1000 Hz; Biometrics, Ladysmith, VA) with an inter-electrode distance of 2.0
cm and electrode diameter of 1.0 cm to record all muscle activity. The EMG amplifier used
for data collection had a bandwidth of 20-460 Hz. We placed all electrodes according to
the procedure of Winter and Yack [141].
For post-processing the EMG data, we high-pass filtered all EMG signals with a 35 Hz
cut-off frequency (3rd order Butterworth filter, zero-lag) and then full-wave rectified. We
then low-pass filtered all rectified signals with a 10 Hz cut-off frequency (3rd order Butter-
worth filter, zero lag) to achieve the signal’s linear envelope. Each linear envelope was then
epoched by stride (heel-strike to heel-strike) and averaged. We normalized each muscle’s
linear envelope by its corresponding peak voltage from the end of the 1st unpowered walk-
ing portion of the session [141]. We additionally calculated the root mean square (r.m.s.)
stride average for the rectified EMG signal. The r.m.s. calculations were normalized by
the average r.m.s. from the end of the 1st unpowered portion of each session. All EMG
normalization was done prior to averaging.
4.2.7 Kinematics
We measured joint kinematics during treadmill walking using a 10-camera motion capture
system (sample rate: 100 Hz; Vicon, Oxford, UK). We used a 39 reflective marker set for
each subject (34 on the pelvis and lower limbs, 4 on the torso, and 1 on the head). All joint
kinematics were calculated from raw marker data using OpenSim 3.2 [34]. In OpenSim
we scaled a generic model to subject specific marker placements. The model consisted of
lower extremities and a trunk with 23 degrees of freedom and 54 actuators. We ensured
that all subject model scaling and inverse kinematic r.m.s. values were within the range
recommend by OpenSim during processing [67].
We calculated the Pearson product moment correlations between the mean joint kine-
matics from the end of powered conditions to the end of 1st unpowered conditions. We
assessed similarities in powered verses unpowered joint kinematics by the coefficient of
determination (R2) of these correlations [59].
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4.2.8 Joint Mechanics
We imported all ground reaction force data into OpenSim 3.2 to use in conjunction with
the calculated joint kinematics to perform inverse dynamics. We scaled each model’s mass
anthropomorphically using the subject’s mass and then manually included additional mass
at the shank and foot to account for the exoskeleton. We used OpenSim’s residual reduc-
tion algorithm (RRA) to iteratively adjust the model as needed to get residual forces and
moments as low as possible. We used the adjusted model to calculate inverse dynamics.
Our final residuals after using the RRA can be seen in Table 4.1. These residuals are within
OpenSim’s recommended ranges with the exception of Fy maximum and Fz root mean
square which are marginally outside of the recommended ranges [67]. We believe these
values are acceptable and we attribute the larger residuals to the added complexity of the
exoskeleton being present in the analysis.
To calculate all joint powers, we multiplied joint angular velocities by the joint torque.
We took a simple derivative of the joint positions to get the joint angular velocities and
filtered them with a 25 Hz cut-off frequency (3rd order Butterworth, zero-lag) to remove
the amplified noise that resulted from taking the derivative. We calculated biological ankle
power by subtracting the exoskeleton power from the total ankle power at each time in-
stance. We calculated average joint power values by taking the time interval of the power
time series data and dividing it by corresponding stride periods [33, 42]. Average positive
and negative power values were computed by separating out the time integrals to periods of
positive and negative power. Average net power was calculated using the time series of all
power data. Following methodology from [42], we assessed total average positive power,
P
+
Tot, as the sum of average positive power from the ankle, knee, and hip (P
+
Ankle, P
+
Knee,
P
+
Hip, respectively).
P
+
Tot = P
+
Ankle + P
+
Knee + P
+
Hip (4.10)
Table 4.1: Average residual values after final run of the RRA in OpenSim
Fx Fy Fz Mx My Mz pErrx pErry pErrz
(N) (N) (N) (Nm) (Nm) (Nm) (cm) (cm) (cm)
Maximum 12.9 33.3 17.4 29.3 40.6 40.6 3.8 2.3 0.4
Root Mean Square 7.4 9.6 11.1 9.8 19.3 11.1 2.6 1.5 0.2
Fx, Fy , and Fz refer to the residual forces at the pelvis. Mx, My , and Mz refer to the residual moments at the
pelvis. pErrx, pErry , and pErrz refer to the translational position error of the markers.
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4.2.9 Exoskeleton Mechanics
The distance from the base of the actuator attachment to the exoskeleton joint center was
10.07 cm. Knowing the ankle joint angle from the inverse kinematics, we calculated the
moment arm on the actuator at each time instance of collection. We filtered all load cell
data with a 25 Hz cut-off frequency (3rd order Butterworth filter, zero-lag). We multiplied
the filtered force data by the calculated moment arm to get the exoskeleton torques. The
calculated exoskeleton torques were multiplied by the ankle angular velocities to calculate
the exoskeleton power. We calculated average exoskeleton power values the same way as
average joint power values. We calculated exoskeleton mechanics from one exoskeleton
per subject.
4.2.10 Statistical Analyses
We performed two types of repeated-measures ANOVA analysis using SPSS Statistics 22
(IBM, Armock, NY) on all data of interest with a significance level set to 0.05. One
ANOVA analysis compared across the four time windows of each training session. An-
other ANOVA analysis compared across the training sessions of each time window.
4.3 Results
4.3.1 Metabolic Cost
As subjects began to adapt to the exoskeleton, the amount of metabolic power required to
walk in the device decreased (Figure 4.3). Subjects had a significant decrease in metabolic
Table 4.2: Resulting net metabolic cost from each time interval across sessions
1st Unpowered Powered Powered 2nd Unpowered Within Session
Minutes 7-10 Minutes 3-6 Minutes 27-30 Minutes 7-10 P-Value
Session 1 3.94 ± 0.25 3.72 ± 0.18 3.30 ± 0.15 3.86 ± 0.24 0.002
Session 2 3.75 ± 0.18 3.31 ± 0.19 3.08 ± 0.14 3.75 ± 0.20 0.024
Session 3 3.66 ± 0.18 3.14 ± 0.11 3.01 ± 0.08 3.74 ± 0.15 0.006
Across Session
P-Value
0.070 0.028 0.193 0.614 —
Net metabolic rates are all expressed in units of W kg−1 (mean ± s.e.m.). P<0.05 represents statistical signifi-
cance.
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power in every session (all P<0.05). By the end of powered walking in session 3, subjects
were able to walk with a net metabolic power of 3.01 ± 0.08 W kg−1 (mean ± s.e.m.,
here and throughout). Compared to the first unpowered condition of that same session,
3.66 ± 0.18 W kg−1, this was a reduction of 17.8%. All net metabolic power values are
listed in Table 4.2.
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Figure 4.3: Metabolic results from each training session. The top axis shows the mean net
metabolic power required by eight subjects to walk in the exoskeleton across the three training ses-
sions. All net metabolic power values are normalized by subject mass. The bottom axis represents
the powered conditions of this same data as a mean percent change in net metabolic power. Error
bars represent ± 1 s.e.m.
There was a large change in metabolic power during powered minutes 3-6 across ses-
sions. During session 1, subjects had a net metabolic power of 3.72 ± 0.18 W kg−1, a
reduction of 5.6% compared to the 1st unpowered condition. By session 3, net metabolic
power was 3.14±0.11 W kg−1, a reduction of 14.2% compared to the 1st unpowered condi-
tion. Statistically, there was a significant reduction in net metabolic power during powered
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minutes 3-6 across the three sessions (P=0.028).
4.3.2 Dynamically Adjusted Gain
By the end of session 3, our adaptive controller chose gains that resulted in β = 1.50 ±
0.14 (mean ± s.e.m. between subjects; we averaged βi over the final three minutes of the
powered session to calculate β). The average gain values from the final three minutes of
each session showed no significant difference across sessions (P=0.273).
4.3.3 Electromyography
During session 1, subjects quickly reduced their soleus activation levels (Figure 4.4 and
Additional file 2: Table A2 of [89]). At the beginning of the powered condition of session
1, subjects reduced their soleus r.m.s. EMG by 13.8 ± 3.8% compared to the end of the
1st unpowered condition. By the end of that same session, subjects had achieved a soleus
r.m.s. EMG reduction of 20.3 ± 8.2% (28.0 ± 6.8% reduction in peak linear envelope).
Contrary to previous studies, subjects preferred to increase their soleus recruitment with
additional training sessions. By the end of session 3, subjects were walking with a soleus
r.m.s. EMG reduction of only 10.8±7.9% (21.5±4.8% reduction in peak linear envelope).
The medial gastrocnemius EMG showed no significant change during testing.
Across testing sessions, subjects adapted to use less rectus femoris recruitment when
walking in the powered exoskeleton (Figure 4.4 and Additional file 2: Table A2 of [89]).
By the end of the powered condition of session 3, subjects had adapted to reduce their
rectus femoris r.m.s. EMG by 20.2 ± 9.2% compared to the 1st unpowered condition. As
subjects learned to walk in the exoskeleton, their rectus femoris activity decreased across
sessions during the powered minutes 3-6 (P=0.005). The most noticeable change was the
reduction in peak EMG activity shown by Figure 4.4. By session 3, subjects were able to
reduce their peak rectus femoris activation level around toe off by 43.8± 13.8% compared
to the 1st unpowered condition. Unlike the rectus femoris EMG, the vastus lateralis EMG
showed no r.m.s. reduction during powered walking. The biceps femoris long head EMG
r.m.s. values showed significant reductions during each session (all P<0.05), yet the re-
duction observed during the end of the powered condition lasted through the end of the 2nd
unpowered condition (Additional file 2: Table A2 of [89]).
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Figure 4.4: Soelus and rectus femoris results from each training session. (A) The mean soleus
and mean rectus femoris EMG linear envelope (high-pass cutoff frequency of 35 Hz and low-pass
cutoff frequency of 10 Hz) of eight subjects is represented by the solid lines and +1 s.d. is repre-
sented by the dashed lines. (B) The mean soleus and mean rectus femoris r.m.s. of rectified EMG for
four time intervals is indicated by the colored bars across all three sessions. Error bars represent±1
s.e.m. Each subject’s r.m.s. values were normalized to the corresponding session’s 1st unpowered
r.m.s. value prior to averaging.
4.3.4 Joint Kinematics
Subjects had the largest change in joint kinematics at the ankle when comparing powered
to unpowered conditions (Figure 4.5). A linear regression between ankle kinematics from
the end of the powered condition in session 3 and the 1st unpowered condition of that same
session had anR2 value of 0.58±0.11. This lack of correlation between the two conditions
is due to the fact that subjects plantar flexed∼8-9o more throughout the mid and late stance
phase (30-60% gait cycle). Subjects continued to increase peak plantar flexion from session
1 (23.5o) to session 3 (27.3o). The powered peak plantar flexion values are large compared
to the 1st unpowered condition (12.9o).
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Figure 4.5: Joint kinematics, dynamics, and power from the beginning and end of training.
Mean joint angles, moments, and powers from eight subjects. Joint dynamics and power have been
normalized by subject mass. In the kinematics and dynamics plots all positive numbers represent
extension while all negative numbers represent flexion.
Little change was observed in the knee and hip kinematics. All hip and knee linear
regressions comparing the end of the powered condition to the 1st unpowered condition of
each session had R2 values greater than 0.97.
4.3.5 Joint Mechanics
The relationship between subjects’ actuation control signal magnitude and exoskeleton
torque output was approximately linear with an R2 value of 0.74 ± 0.13 by the end of
session 3. The mean total moment at the ankle (biological and exoskeleton) increased
∼0.16-0.18 Nm kg-1 (∼47.8%) during the early to mid stance phase (0-30% gait cycle)
when comparing the end powered conditions to the average unpowered condition (Fig-
ure 4.5). This increase in total ankle plantarflexion moment during the early to mid stance
phase corresponds with a decrease in hip flexion muscle moment. Subjects experienced a
decrease in mean hip flexion muscle moment ∼0.14-0.15 Nm kg-1 (∼31.7%) during this
phase of the gait. There was little change in knee joint dynamics.
Subjects increased positive average total ankle power when the exoskeleton was pow-
ered (P=0.001; Figure 4.6). Most noticeably, subjects walked with a 0.13 ± 0.01 W kg-1
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Figure 4.6: A breakdown of ankle power contributions from each training session. (A) Mean
total ankle power, exoskeleton power, and biological ankle power from eight subjects across all three
sessions. The exoskeleton power was calculated from ankle kinematics and force outputs. The bio-
logical power was calculated by subtracting the exoskeleton power from the total ankle power. (B)
Average power plots of positive, negative, and net power for total ankle power, exoskeleton power,
and biological ankle power. All error bars represent ±1 s.e.m. An astrix represent significance
across all four conditions (ANOVA, P<0.05) and a double astrix represents significance in both all
four conditions as well as just across sessions 1-3 (ANOVA, P<0.05).
71
(65.8 ± 8.9%) increase in positive average total ankle power by session 3 relative to the
average unpowered condition. Across training sessions, subjects increased their positive
ankle exoskeleton power as they adapted to the device (P=0.019). Subjects had no sig-
nificant change in net biological power output between powered and average unpowered
conditions (P=0.614). There was no significant difference in average net knee power be-
tween powered and average unpowered conditions (P=0.195), yet a decreasing trend of the
magnitude was observed. Between the average unpowered condition and the end of ses-
sion 3’s powered condition, there was a 25.4% reduction in the magnitude of the average
net knee power. There were significant differences in average positive hip power between
powered and average unpowered conditions (P=0.003). By session 3, subjects walked with
an average positive hip power 0.06 ± 0.01 W kg-1 (14.7 ± 2.5%) less than that of the 1st
average unpowered condition (Figure 4.7).
Subjects increased the amount of average total positive power, P
+
Tot, from the average
unpowered condition to the end of the powered sessions (P=0.009). Additionally subjects
altered percent contributions of the ankle and hip joint to P
+
Tot (P=0.002 and P=0.002
respectively; Figure 4.8). There was no significant change in percent contributions from
the knee between conditions (P=0.165). Percent contributions from the ankle increased
from 27.7 ± 1.9% to 41.2 ± 1.0% between the average unpowered condition and the end
of the powered condition of session 3. Percent contributions from the hip decreased from
52.8 ± 1.6% to 41.3 ± 0.9% between the average unpowered condition and the end of the
powered condition of session 3.
4.4 Discussion
The results from this study support our hypothesis that subjects would learn to reduce their
energetic cost when walking in the robotic ankle exoskeletons. By the end of the session
3, subjects required 3.01 ± 0.08 W kg−1 to walk in the powered device. This result is
comparable to that of previous studies using a traditional proportional myoelectric con-
troller [116]. An important difference between our metabolic results and that of previous
studies is that all eight of our subjects experienced a metabolic reduction by the end of
session 1’s powered condition. In previous studies, the mean metabolic reduction by the
end of session 1’s powered condition was approximately zero. Additionally, in previous
work subjects had to complete three full training sessions before additional training had no
effect metabolic power reduction. In our current study there was no statistically significant
difference in net metabolic power reduction at the end of the powered condition across
sessions (P = 0.193). Although the mean metabolic values at the end of each session’s
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Figure 4.7: A breakdown of knee and hip power contributions from each training session. (A)
Mean knee power and mean hip power from eight subjects. (B) Average power plots of positive,
negative, and net power for knee and hip power. An astrix represent significance across all four
conditions (ANOVA, P<0.05).
powered condition suggests slight training effects, the percent reduction between the first
unpowered condition and end of the powered condition on session 1 was 16.2% were on
session 3 it was 17.8%. These results suggests that the learning rate with an adaptive pro-
portional myoelectric controller is faster than that of a traditional proportional myoelectric
controller. Despite no significant difference in net metabolic power reduction at the end of
the powered condition across sessions, the rate at which subjects reached this net metabolic
power reduction increased with additional training sessions. This is made evident by the
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significant differences in net metabolic power during the beginning of the powered con-
dition across sessions (P=0.028; Figure 4.3 and Table 4.2). These metabolic results show
that an adaptive gain proportional myoelectric controller can positively assist users. It is
important to note that the control scheme presented here is not the first variation on the
traditional proportional myoelectric control algorithm [129]; however, to the best of our
knowledge it is the first to implement an adaptive gain.
In addition to the metabolic reductions, our results also suggest that subjects preferred a
β value smaller than that used in our previous work (β = 1.50±0.14 versus a constant β =
2). We found that subjects had no statistical difference in final β gains between sessions
(P=0.273) which suggests the gain converged to a steady state value after only one session.
According to Equation Eq. (4.7), this smaller gain should lead to a larger total joint activity
compared to unassisted walking (XTot > XBio). This relationship might seem unintuitive
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Figure 4.8: Total positive power contributions from each joint. Mean ankle (dark), knee
(medium), and hip (light) percent contributions to total positive power from eight subjects during
unpowered and powered walking.
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at first, but it is important to note that in both cases the exoskeleton is operated close to its
maximum capacity of X̂Exo. Given a smaller gain β, the user’s contribution XBio was larger
than that of previous studies without oversaturating XExo. It is this contribution from the
user that leads to a larger total joint activity at the ankle. Our prediction of increased XTot
as a result of a smaller β manifested itself in this study by an increase in positive average
total ankle power. Positive average total ankle power increased from 0.21 to 0.35 W kg-1
between unpowered and powered conditions on session 3. The exoskeleton provided 0.17
W kg-1 additional average positive power, while the biological average positive power was
reduced by only 0.02 W kg-1. We did not observe an increase in total ankle power with our
previous work using a static gain proportional myoelectric controller. Our methodology
for tuning β in the past may have constrained users to using levels of total ankle power no
larger than that of unassisted walking in the device.
This increase in positive average total ankle power led to significant changes in hip joint
mechanics. Positive average hip power decreased from 0.41 to 0.35 W kg-1 between un-
powered and powered conditions on session 3. Additionally, our results show that subjects
chose to increase ankle contribution to total positive power (27.7 to 41.2%) in exchange for
a decrease in hip contribution (52.8 to 41.3%) between these conditions. We acknowledge
that the baseline of the unpowered condition is shifted from walking without an exoskele-
ton most likely due to the added mass of the device. As a point of reference, Farris et al.
showed that in healthy subjects walking without any exoskeleton at 1.25 ms-1 (compared
to 1.2 ms-1 in this study) about 46% of the total average positive power comes from the
ankle while 40% comes from the hip [42]. Although the percent contributions of power at
the end of session 3 in this study look similar to those reported by Farris et al., we would
not conclude that subjects adapted back to normal unassisted gait dynamics. We would not
make this conclusion due to the large differences in power and moment profiles of each
individual joint from this study compared to that of previously reported profiles of healthy
unassisted walking [42, 142]. Our results emphasize that replicating unassisted joint me-
chanics with assistive devices may not be the best approach to lowering metabolic power.
We also observed a trade-off in soleus EMG activity and rectus femoris EMG activity.
This result agrees with previous studies such that ankle assistance can lead to decreases in
activity at muscles not associated with the ankle [50, 53].
Research has shown that a trade-off between ankle and hip mechanics exists in unas-
sisted locomotion. The possibility of redistributing joint powers has been shown for ex-
ample by Lewis et al. [95]. When subjects were asked to walk with an increased ankle
push off, the power at their hip decreased. However, little has been said about the energetic
implications of this trade-off with human subject testing. In 2002, Art Kuo showed in sim-
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ulation that increasing work at the ankle can be energetically economical in comparison
to doing so at the hip [90]. He further hypothesized that it is only biological limitations
that prevent us from using more ankle work in practice. Our results might point in the
same direction. During unpowered walking, the ratio of hip to ankle contribution that we
observe is larger than that reported in previous literature [42, 117]. This may be a conse-
quence of the increase in required total positive joint power that results from the mass of
the exoskeletons which is added distally to the legs. We believe that this additional power
is primarily produced at the hip because there exists a biological limitation preventing the
ankle from comfortably providing more positive power. With the added power of the ex-
oskeleton, however, subjects were able to increase contributions from the ankle and reduce
the effort put forth at the hip. Our findings that an ankle exoskeleton can reduce effort at
the hip can potentially be applied to musculoskeletal hip rehabilitation. Given that subjects
showed large reductions in average positive hip power, an ankle exoskeleton could be a
viable option for those in need of hip assistance yet more testing is necessary to say for
certain.
4.5 Conclusion
This study used an adaptive proportional myoelectric controller on bilateral ankle exoskele-
tons to test if users could adapt to the controller to reduce metabolic power and see what
β gain they chose when given an adaptive controller. Subjects demonstrated that a signif-
icant metabolic reduction can be met after only one day of training. Subjects adapted to
a β gain smaller than that used in previous work with traditional proportional myoelectric
controllers. This smaller β gain allowed subjects increased amounts of total ankle power
compared to unassisted walking and resulted in reduced power output at the hip.
More research is needed to be done in adaptive control of assistive devices to gain a
better understanding of how subjects co-adapt with these systems. However, we believe
that an adaptive nature of control parameters will be key to developing better assistive
devices.
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CHAPTER 5
Biomechanics and Energetics of Walking in
Powered Ankle Exoskeletons Using Myoelectric
Control versus Mechanically Intrinsic Control
5.1 Background
When it comes to designing the control of lower extremity assistive robotic devices, such
as exoskeletons or prostheses, there are a wide variety of control strategies to choose from.
Ideally, with the correct control architecture and proper tuning, these devices can work in
parallel with the user to aid in their locomotion [77, 101, 106, 111, 152]. There have been
many different control strategies explored in research, but there is a lack of knowledge in
knowing what type of control to use for certain applications and why.
Lower extremity robotic devices have traditionally been separated into two main ap-
proaches for device control. The device assistance can either be driven by neural signals
or mechanically intrinsic signals. Control driven by neural signals relies on the already
existing control architecture of the human body. By tapping into physiological electrical
signals, such as brain activity or muscle activity, these controllers can decode human in-
tention and actuate the device accordingly [68, 83, 116]. Control driven by mechanically
intrinsic signals relies on measures that are intrinsic to the device itself, such as detected
gait events, joint angles, or forces [4, 49, 79, 97]. In doing so, these devices are trying to
infer human intention from secondary information to drive actuation. For example, a joint
angle may be used as a phasing variable for the onset of a predefined actuation signal [112].
Each of these control approaches has its own advantages and disadvantages. For exam-
ple, control driven by neural signals is often argued to have better human-device synchro-
nization over control driven by mechanically intrinsic signals [147]. Neural signals can
The content of this chapter has been submitted and is currently under review for publication in the Journal
of NeuroEngineering and Rehabilitation.
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be measured before force generation at the muscle has actually occurred due to the elec-
tromechanical delay of the body [30]. Therefore, there is a buffer of time between sensing
of a neural signal and delivering actuation that is synchronous with the user’s movement.
In contrast, mechanically intrinsic signals can only be sensed after movement has already
occurred. This creates an inherent lag behind the user when using control driven by me-
chanically intrinsic signals, yet if designed properly this lag may be indistinguishable by
the user [36, 151]. Another advantage for control driven by neural signals is that it can
allow for direct control by the user. With proportionality in the control scheme, users can
directly control the timing and amplitude of actuation at any time instance using the same
neurological control they would adjust their own muscle contraction timing and amplitude.
This proportionality can lead to a more natural means of control and adaptation compared
to a controller driven by mechanically intrinsic signals [25]. One big advantage of using
mechanically intrinsic signals to drive control is the reduced complexity over neural sig-
nals. Sensors used to measure mechanically intrinsic signals can be self-contained in the
device and produce consistent and repeatable measurements. With neural signals, the elec-
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Figure 5.1: Control algorithms used in testing and the experimental setup. (A) All eight
subjects completed separate 10 minute walking trials with two different control schemes. The dy-
namic gain proportional myoelectric controller (blue) created a actuation signal proportional to
subject’s soleus muscle recruitment. The timing-based mechanically intrinsic controller (yellow)
sent through the same predefined actuation signal triggered by each heel strike. The two controllers
were designed to have the same average actuation signal. (B) Subjects walked at 1.2 ms-1 with
pneumatically powered bilateral ankle exoskeletons. During testing we measured subjects’ joint
kinematics and dynamics (motion capture and instrumented treadmill), muscle activity (EMG elec-
trodes), exoskeleton kinetics (load cells), and energy consumption (indirect calorimetry).
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trodes used for electroencephalography (EEG) or electromyography (EMG) can have large
variability depending upon placement and skin conditions. With relatively high noise con-
tent, neural signals require extensive decoding or filtering before they can be used in real
time.
Despite the prevalence of these two types of controller designs, to date, there does
not exist any systematic and fair comparison of how they differently affect the biome-
chanics and energetics of individual users. In the work presented here, we designed an
experiment to make a close comparison between a controller driven by neural signals (a
proportional myoelectric controller based on soleus muscle recruitment) and a controller
driven by mechanically intrinsic signals (a timing-based mechanically intrinsic controller
based on gait events). We tested both controllers with healthy subjects wearing bilateral
ankle exoskeletons and aimed to better understand users’ biomechanical and energetic re-
sponses to each during steady-state treadmill walking (Fig. 5.1). We designed these two
controllers to have the same average actuation signal such that the main difference between
them was the way in which the actuation was driven. To ensure the same average actuation
signal, we created the actuation profile for the timing-based controller directly from the
average of control signals seen during use with the proportional myoelectric controller. In
previous work, we have mathematically derived the inherent relationship between muscle
activation and device output when using a proportional myoelectric controller [89]. The
timing-based controller we are showing here does not have such dependency so the actu-
ation signal was consistently the same regardless of the user’s soleus muscle recruitment.
Our primary hypothesis was that the human nervous system would identify this key dif-
ference between controllers and therefore use each in a distinct way, thus resulting in a
difference in metabolic work rate between the two controllers. We have investigated where
some of these differences in use may be by analyzing subject’s muscle recruitment, joint
kinematics, and joint dynamics.
5.2 Methods
5.2.1 Subjects
In this study we tested eight healthy subjects with no prior experience walking in powered
exoskeletons (male, 21 ± 1 years, 74.0 ± 2.7 kg, 180.0 ± 2.8 cm; mean ± standard error
of the mean). We pre-screened all participants for exoskeleton hardware fit prior to testing.
All subjects gave informed written consent to participate in the study in accordance to the
University of Michigan Medical School’s Institutional Review Board.
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5.2.2 Exoskeleton Hardware
The bilateral ankle exoskeletons that we used in this study were similar in design to our
previous work [44, 45, 59, 116]; however, we designed these exoskeletons to be more ad-
justable and versatile to fit a number of subject sizes. These were the same exoskeletons as
presented in [89].
The exoskeletons consisted of an adjustable shank component attached to a shoe com-
ponent by a single degree of freedom rotational joint. The rotational joint constrained the
exoskeleton’s motion to plantar flexion and dorsiflexion. The shank component was made
from stainless steel rods and plastic cuffs. We used ratchet straps on the cuffs to fit the
shank to different subject sizes. The shoe component was a standard orthotic shoe that we
outfitted with metal attachments for actuation and joint coupling. The exoskeleton could
accommodate subjects that wore between a 9 and 11 U.S. men’s shoe size.
We actuated the exoskeletons using custom built artificial pneumatic muscles attached
posteriorly. These actuation units only provided plantar flexion assistance to the user [44].
We attached a load cell in series (Omega Engineering, Stamford, Connecticut) with the
actuator to measure actuation kinetics. The shoe, shank, actuator, and load cell combined
to a total mass of 2.08 kg (approximately 0.81 kg at the foot and 1.27 kg at the shank).
5.2.3 Exoskeleton Control
In this study we used two different controllers, a dynamic gain proportional myoelectric
controller and a timing-based mechanically intrinsic controller, on the same exoskeleton
hardware. We built both of these controllers in Simulink (The MathWorks, Inc., Natick,
MA) and compiled them to run on a real-time control board (dSPACE, Inc., Northville,
MI).
5.2.3.1 Dynamic Gain Proportional Myoelectric Control
The proportional myoelectric controller was driven by user’s soleus EMG activity. We mea-
sured subjects’ soleus activity in real time using EMG surface electrodes (sample rate: 1000
Hz; Biometrics, Ladysmith, VA). The designed controller then processed the recorded sig-
nal into its linear envelope by high-pass filtering (2nd order Butterworth, cutoff frequency
80 Hz), full-wave rectifying, and then low-pass filtering (2nd order Butterworth, cutoff
frequency 4 Hz) the raw signal.
The controller multiplied the calculated linear envelope by a gain to linearly map the
small voltage of the processed EMG signal into a larger control voltage that was sent to
the pneumatic pressure control valves (MAC Valves, Wixom, MI). We applied a threshold
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Figure 5.2: Creating the timing-based control signal for a representative subject. (A) The
actuation signals from 80 of the final 100 strides of a subject’s walking bout with the dynamic gain
proportional myoelectric controller were considered in creating the actuation signal for the timing-
based controller. Those 80 strides are shown here for a single representative subject and from a
single leg. The darker the color of the actuation signal, the later in the walking bout it occurred (B)
The actuation signal for the timing-based mechanically intrinsic controller was generated from the
average of the 80 strides considered from the walking bout with the myoelectric controller.
to this control signal such that the commanded pneumatic pressure needed to be greater
than 20 pounds per square inch (p.s.i) in order to actuate as the pneumatic muscles were
pretensioned with this pressure to allow for a faster response time. The maximum output
pressure of our pressure source was 90 p.s.i. and control signals were saturated beyond
this point. The controller was designed to continuously tune the linear mapping gain on
a subject-specific basis using a dynamically adaptive algorithm as described in [89]. This
algorithm tuned the gain such that the average peak EMG signal over the previous 50
strides mapped to a desired maximum control signal voltage. We chose a desired maximum
control voltage that resulted in the peak of the average control signals to be the maximum
output pressure of the valves (90 p.s.i.). This created a controller that, on average, supplied
maximal peak actuation to the user at the same moment when they reached their maximal
peak soleus activity for that given stride. In this control scheme, the user could adapt
their own muscle activity to whatever level they felt comfortable with, while still receiving
maximal peak power output from the device.
5.2.3.2 Timing-Based Mechanically Intrinsic Control
The timing-based mechanically intrinsic controller was driven by detected heel strikes as
sensed by an instrumented treadmill (Bertec Corporation, Columbus, OH). We designed
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this controller to have the same average actuation signal as that of the proportional myo-
electric controller (Fig. 5.2). To generate the actuation profile for this timing-based con-
troller, we first normalized the actuation signals from the final 100 strides of a subject’s
walking bout using the proportional myoelectric controller by their percent gait cycle (heel
strike to heel strike). We then averaged these 100 normalized actuation signals. We calcu-
lated the root mean squared error (RMSE) for each of the 100 individual stride’s actuation
signal compared to this average and then discarded the 20 strides strides with largest RMSE
values to safely remove any outliers. We then averaged the remaining 80 strides’ actuation
signals to generate the actuation profile for the timing-based mechanically intrinsic con-
troller. This whole process was performed separately for each individual subject and leg.
During walking, the timing-based controller would assist with plantar flexion upon each
detected heel strike. This process was equivalent to pressing a “play” button on the pre-
defined actuation signal with each heel strike. If a stride was shorter than the averaged
control signal, the signal would start over immediately. If a stride was longer than the
averaged control signal, the actuators remained at a pressure that resulted in zero force
generation until the next detected heel strike occurred.
5.2.4 Testing Protocol
We trained all participating subjects in this study to walk with the powered ankle exoskele-
tons prior to the data collection presented here. All subjects had no experience with walking
in a powered assistive device prior to this training. In recruiting a naive subject pool, we
have ensured that all subjects were given the same amount of time to adapt and learn to
walk in the exoskeletons. The training consisted of three separate days of walking with
the exoskeletons using the dynamic gain proportional myoelectric controller. During these
training sessions, subjects walked continuously on a treadmill at a fixed speed in the ex-
oskeletons for 50 minutes, the middle 30 of which were powered. A more detailed descrip-
tion of these sessions and subjects’ adaptations is described in [89].
After completing the three training sessions, we tested subjects on a separate fourth day
to collect the data presented here. During this final testing session, subjects participated
in four walking bouts that were each 10 minutes long. Subjects were given a seated rest
period of 5-10 minutes between bouts. First, subjects walked in the exoskeletons without
any actuation. We will refer to this bout as the unpowered condition. Subjects then walked
using the dynamic gain proportional myoelectric controller in order to re-familiarize them-
selves with the devices and to generate the data necessary to build the control signals for
the timing-based mechanically intrinsic controller. This walking bout served purely as a
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warm up for subjects and a calibration for the timing-based controller. As such, no re-
sults from this bout are presented here. After the warm up session, subjects walked using
the timing-based mechanically intrinsic controller and then walked using the dynamic gain
proportional myoelectric controller. We will refer to these bouts as the timing-based and
the proportional myoelectric controller conditions, respectively. All walking bouts took
place at 1.2 m/s on an instrumented treadmill. We considered the final three minutes of
each walking bout for respiratory analysis and the final 25 strides of each walking bout for
all gait analyses. We normalized all stride-related data from heel-strike (0% gait cycle) to
heel-strike (100% gait cycle) of the same leg.
5.2.5 Metabolic Cost
We measured subjects’ O2 and CO2 flow rates during walking using a portable open-circuit
indirect calorimetry system (CareFusion Oxycon Mobile, Hoechberg, Germany). We con-
verted these measurements to metabolic power using formulas from Brockway [19]. We
recorded a three minute standing trial from each subject at the beginning of the testing
session and averaged it to get subjects’ standing metabolic work rate. This calculated
standing metabolic work rate was then subtracted from each walking bout to calculate the
net metabolic work rate [63]. We analyzed each walking bout by averaging the final three
minutes of recorded walking metabolic data, and then normalized these averages by sub-
jects’ body mass. During all testing, subjects remained in the aerobic range of exertion as
all respiratory exchange ratios were less than one [20].
5.2.6 Electromyography
We measured muscle activity from the soleus, tibialis anterior, medial gastrocnemius, bi-
ceps femoris long head, vastus lateralis, rectus femoris, and gluteus maximus using elec-
tromyography (EMG). All EMG recordings and analysis, except for the soleus, came solely
from the subjects’ right leg. Soleus activity was recorded and analyzed from both the left
and right legs since soleus activity was used as a control input for the proportional myo-
electric controller. We recorded all muscle activity using bipolar surface electrodes (sam-
ple rate: 1000 Hz; Biometrics, Ladysmith, VA) with an inter-electrode distance of 2.0 cm
and electrode diameter of 1.0 cm. The EMG amplifier had a bandwidth of 20-460 Hz.
We placed all electrodes on subjects’ legs in accordance to the procedures of Winter and
Yack [141].
During post processing, we high-pass filtered all raw EMG signals with a 35 Hz cut-off
frequency (3rd order Butterworth filter, zero-lag) and then full-wave rectified the filtered
83
signals. To compute the signals’ linear envelopes, we low-pass filtered the rectified signals
with a 10 Hz cut-off frequency (3rd order Butterworth filter, zero lag). Each linear enve-
lope was then parsed by stride (heel-strike to heel-strike), normalized to stride cycle, and
averaged. We normalized each muscle’s linear envelope amplitude by its corresponding
average peak voltage from the unpowered walking bout on a subject-specific basis [141].
In addition to the linear envelopes, we calculated the root mean square (r.m.s.) stride aver-
age for the rectified EMG signals. We normalized each muscle’s r.m.s. stride average by its
corresponding average from the unpowered walking bout on a subject-specific basis. All
EMG normalization was done prior to averaging.
5.2.7 Kinematics
All subjects wore a 39 reflective marker set during testing (34 on the pelvis and lower
limbs, 4 on the torso, and 1 on the head). We tracked all marker positions using a 10-
camera motion capture system (sample rate: 100 Hz; Vicon, Oxford, UK). We calculated
joint kinematics from the raw marker data using OpenSim 3.2 [34]. In OpenSim we scaled
a generic 23 degree of freedom, 54 actuator model to subject specific marker placements.
During processing, we ensured that all subject model scaling and inverse kinematic root
mean square values were within the range recommend by OpenSim documentation [67].
We calculated the Pearson product moment correlations between different joint kine-
matic measurements across different walking bouts. We assessed similarities in joint kine-
matics by the coefficient of determination (R2) of these correlations [59]. R2 values ap-
proaching 1 indicate strong similarities in joint trajectories as an R2 value equal to 1 in-
dicates a perfect match in trajectories. R2 values close to 0 indicate strong differences in
trajectories.
We calculated all gait kinematic measures (step length, step width, step period, double
support period) using motion capture data from the left and right calcaneus markers. All
gait events were sensed using ground reaction force data from the instrumented treadmill.
All raw motion data was first low-pass filtered using a 5 Hz cut-off frequency (3rd order
Butterworth filter, zero-lag) to remove any motion artifact. Step length and step width were
defined as the fore-aft and lateral distances, respectively, between the calcaneus markers at
the time of detected heel strike. Step period was defined as the time between heel strikes
of opposite feet, and double support period was defined as the time between heel strike of
one foot and the toe off of the other.
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5.2.8 Joint Mechanics
To perform inverse dynamics, we imported all ground reaction force data into OpenSim 3.2
and used it in conjunction with the calculated joint kinematics. Each subject model’s mass
was scaled anthropomorphically with the manual addition of the mass at the shank and foot
to account for the exoskeletons. We removed as much of the residual forces and moments
of the inverse dynamics as possible by iteratively adjusting the model using OpenSim’s
residual reduction algorithm (RRA). All of the final residuals after using the RRA were
within OpenSim’s recommended ranges. They are presented in Table 5.1 [67].
We took the numerical derivative of the joint positions to calculate the joint angular
velocities. We filtered these velocities with a 25 Hz cut-off frequency (3rd order Butter-
worth, zero-lag) to remove any amplified noise that may have resulted from the numerical
differentiation. We then multiplied these calculated joint angular velocities by the joint
torques resulting from the inverse dynamics to calculate joint power. Exoskeleton power
was calculated in a similar fashion, using the calculated ankle angular velocity and the
measured actuation torque from the load cell. We subtracted the exoskeleton power from
the total ankle power at each time instance to calculate the biological ankle power. Average
net joint power was computed by taking the time integral of the power time series data and
dividing it by corresponding stride periods [33, 42]. We computed average positive and
negative power values in the same way, but by separating out the time integrals to periods
of positive and negative power, respectively.
Table 5.1: Average residual values after final run of the RRA in OpenSim
Fx Fy Fz Mx My Mz pErrx pErry pErrz
(N) (N) (N) (Nm) (Nm) (Nm) (cm) (cm) (cm)
Maximum 9.7 9.4 12.5 27.0 43.4 34.7 2.8 1.8 0.6
Root Mean Square 5.3 2.8 7.4 8.6 21.2 9.7 1.9 1.1 0.3
Fx, Fy , and Fz refer to the residual forces at the pelvis, and Mx, My , and Mz refer to the residual moments at
the pelvis. pErrx, pErry , and pErrz refer to the translational position error of the markers.
5.2.9 Exoskeleton Mechanics
We measured the distance of the exoskeleton joint center to the actuator attachment point as
10.07 cm. We were able to calculate the moment arm of the actuator at each time instance
of collection from this distance measure and the calculated ankle kinematics. We filtered
all load cell data with a 25 Hz cut-off frequency (3rd order Butterworth filter, zero-lag) and
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then multiplied it by this calculated moment arm to compute the exoskeleton torques. To
calculate exoskeleton power, we multiplied these torques by the ankle angular velocity. We
calculated average exoskeleton power values in the same way as the average joint power
values. We calculated exoskeleton mechanics from the left exoskeleton for half of the
subjects and the right exoskeleton for the other half due to hardware capabilities during
testing.
5.2.10 Statistical Analyses
For all statistical comparisons we performed a paired t-test (α = 0.05) between walking
conditions with the timing-based controller and the proportional myoelectric controller.
All reported values and measurements from here forward are presented as the mean ± the
standard error of the mean (s.e.m.).
5.3 Results
5.3.1 Metabolic Work Rate
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Figure 5.3: Net metabolic work rate for each tested walking condition. All net metabolic work
rates are normalized to subject mass and represent the absolute changes in energetics for each walk-
ing condition. Error bars are ±1 s.e.m. from the mean of each condition. The percentages above
each powered condition represents the percent decrease in energetics compared to the unpowered
condition.
Walking with the exoskeletons powered, regardless of controller used, resulted in large
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decreases in metabolic work rate compared with the unpowered condition (Fig. 5.3). Net
metabolic work rate of walking in the exoskeletons unpowered was 3.68± 0.23 W kg-1
(mean±s.e.m.). Net metabolic work rate of walking with the timing-based mechanically
intrinsic controller was 2.95± 0.14 W kg-1, or a 19.2± 2.5% decrease compared to the un-
powered condition. Net metabolic work rate of walking with the dynamic gain proportional
myoelectric controller was 2.95± 0.12 W kg-1, or a 19.0± 2.5% decrease compared to the
unpowered condition. There was no significant difference in metabolic work rates between
the timing-based controller and the proportional myoelectric controller (P = 0.966).
5.3.2 Electromyography
The largest change in muscle activity was observed at subjects’ soleus muscle (Fig. 5.4).
When walking with the timing-based controller, subjects achieved a soleus r.m.s EMG re-
duction of 28.2±1.0% and a peak linear envelope reduction of 37.5±3.1% compared to the
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Figure 5.4: Soleus and rectus femoris EMG results from each walking condition. (A) The
mean soleus and rectus femoris EMG linear envelope from each walking condition is represented
by the solid lines and +1 s.e.m. is represented by the dashed lines. (B) The mean soleus and rectus
femoris r.m.s. of rectified EMG across the three walking conditions. All error bars represent ± 1
s.e.m.
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unpowered condition. When walking with the proportional myoelectric controllers, sub-
jects achieved a soleus r.m.s. EMG reduction of 18.6±6.2% and a peak linear envelope re-
duction of 28.8± 4.7% compared to the unpowered condition. Subjects soleus r.m.s. EMG
was less when using the timing-based controller than when using the proportional myo-
electric controller, yet it was not a statistically significant difference (P = 0.132). There
was a distinct qualitative difference in the shape of the two powered walking conditions’
resulting linear envelopes (Fig. 5.4A). Subjects exhibited a significantly lower peak soleus
linear envelope value when using the timing-based controller compared to the proportional
myoelectric controller (P = 0.026). Also, on average subjects showed 11.0 ± 4.9% less
muscle activity with the timing-based controller compared to the proportional myoelectric
controller during the mid and late stance phases of gait (30-50% gait cycle).
Subjects also experienced large reductions in rectus femoris activity during the powered
walking conditions compared to the unpowered condition. When walking with the timing-
based controller, subjects achieved a rectus femoris r.m.s EMG reduction of 8.8±7.5% and
a peak linear envelope reduction of 35.2 ± 20.3% compared to the unpowered condition.
When walking with the proportional myoelectric controllers, subjects achieved a rectus
femoris r.m.s. EMG reduction of 13.0 ± 8.9% and a peak linear envelope reduction of
38.6±15.0% compared to the unpowered condition. There was little to no difference in the
resulting average rectus femoris linear envelopes between the two controllers (Fig. 5.4A).
No statistically significant differences were observed between the two powered conditions
resulting r.m.s. EMG values at the tibialis anterior, medial gastrocnemius, biceps femoris
long head, vastus lateralis, and gluteus maximus (all P > 0.05).
Table 5.2: Resulting mean gait kinematics of each walking bout
Walking Condition
Step Length
(Normalized)
Step Width
(Normalized)
Step Period
(ms)
Double Support Period
(ms)
Unpowered 0.713± 0.010 0.173± 0.011 586.3± 5.6 161.7± 5.0
Timing-Based 0.704± 0.007 0.190± 0.016 591.6± 6.9 167.2± 2.8
Prop. Myoelectric 0.692± 0.008 0.182± 0.014 586.5± 6.6 169.0± 2.2
P -Value 0.004 0.030 0.095 0.256
All values are reported as mean±s.e.m. across subjects. All distance measurements have been normalized by leg length. P<0.05
represents a statistically significant difference between the proportional myoelectric controller and the timing-based controller.
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5.3.3 Gait Kinematics
There were slight differences between walking conditions’ mean gait kinematics (Table
5.2). Subjects exhibited slightly larger mean step lengths and step widths when using
the timing-based controller than when using the proportional myoelectric controller (P =
0.004 and P = 0.030, respectively). There was no statistically significant differences in
gait kinematic variability between the two powered conditions (Table 5.3).
Table 5.3: Resulting gait kinematic variability of each walking bout
Walking Condition
Step Length
(Normalized)
Step Width
(Normalized)
Step Period
(ms)
Double Support Period
(ms)
Unpowered 0.021± 0.002 0.018± 0.002 14.1± 1.2 7.5± 0.6
Timing-Based 0.023± 0.002 0.021± 0.002 17.6± 1.5 9.2± 0.7
Prop. Myoelectric 0.026± 0.004 0.021± 0.001 17.1± 2.2 11.2± 1.1
P -Value 0.231 0.970 0.615 0.210
Variability has been defined as the average standard deviation across subjects. All values are reported as mean±s.e.m. across subjects.
All distance measurements have been normalized by leg length. P<0.05 represents a statistically significant difference between the
proportional myoelectric controller and the timing-based controller.
5.3.4 Joint Kinematics
During powered conditions, subjects experienced the largest deviations from unpowered
walking kinematics at the ankle. Subjects increased plantar flexion by an average ∼14o
during the mid-to-late stance phase of gait when using both the timing-based and the pro-
portional myoelectric controllers compared to the unpowered condition (Fig. 5.5). A linear
regression between ankle kinematics of the timing-based controller and of the unpowered
condition resulted in anR2 value of 0.73±0.05. A linear regression between ankle kinemat-
ics of the proportional myoelectric controller and of the unpowered condition resulted in an
R2 value of 0.71± 0.08. A linear regression between ankle kinematics of the timing-based
controller and the proportional myoelectric controller resulted in anR2 value of 0.98±0.01.
There were little to no changes in joint kinematics at every other joint between con-
ditions. Linear regressions of knee and hip kinematics between powered and unpowered
conditions all resulted in R2 values greater than 0.98. Linear regressions of knee and hip
kinematics between the two controllers all resulted in R2 values greater than 0.99.
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Figure 5.5: Joint kinematics, dynamics, and power from each walking condition. The mean
joint angles, moments, and powers from the unpowered, timing-based mechanically intrinsic con-
trol, and second bout with the dynamic gain proportional myoelectric control conditions. Joint dy-
namics and power have been normalized by subject mass. In the kinematics and dynamics subplots
all positive numbers represent extension while all negative numbers represent flexion.
5.3.5 Joint Kinetics
Subjects increased their mean total moment at the ankle (biological and exoskeleton) by
∼0.14 Nm kg-1 during the early-to-mid stance phase (0-30% gait cycle) when comparing
either of the powered conditions to the unpowered condition (an increase of ∼48.9%, Fig.
5.5). The observed increase in total ankle plantar flexion moment during the early to mid
stance phase corresponds with a decrease in hip flexion moment. Subjects decreased their
mean hip flexion moment ∼0.12-0.15 Nm kg-1 during this phase of the gait cycle when
comparing either of the powered conditions to the unpowered conditions (a decrease of
∼25-31%). Subjects also decreased their mean knee extension moment ∼0.08-0.10 Nm
kg-1 during the mid and late stance phase (30-50% gait cycle) when comparing the powered
conditions to the unpowered condition (a decrease of ∼31-42%).
Subjects showed large increases in positive and net average total ankle power when the
exoskeletons were powered compared to unpowered (Fig. 5.6). When using the timing-
based controller, subjects had an average positive total ankle power 0.13 ± 0.01 W kg-1
and an average net total ankle power 0.15 ± 0.01 W kg-1 larger than that when walking
in the devices unpowered (an increase of 55.2 ± 4.0% and 213.0 ± 38.5%, respectively).
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Figure 5.6: A breakdown of ankle power contributions from each walking condition. (A)
Mean total ankle power, exoskeleton power, and biological ankle power across the three walking
conditions. The exoskeleton power was calculated from ankle kinematics and force outputs recorded
using the exoskeletons’ load cells. The biological power was calculated by subtracting the exoskele-
ton power from the total ankle power. (B) Average power plots of positive, negative, and net power
for total ankle power, exoskeleton power, and biological ankle power. All error bars represent ±
1 s.e.m. An asterisk above the plots represents a significant difference between the two powered
walking conditions (P < 0.05).
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When using the proportional myoelectric controller, subjects had an average positive total
ankle power 0.15 ± 0.01 W kg-1 and an average net total ankle power 0.16 ± 0.01 W kg-1
larger than that when walking in the devices unpowered (an increase of 64.0 ± 3.8% and
222.9 ± 42.3%, respectively). Subjects showed significantly larger average positive and
negative total ankle power when using the proportional myoelectric controller compared to
when using the timing-based controller (P = 0.005 and P = 0.001, respectively). There
was no statistically significant difference in average positive, negative, or net exoskeleton
power out between the two controllers (P = 0.124, P = 0.313, and P = 0.138, respec-
tively). There was also no statistically significant difference in average positive, negative
or net biological ankle power output between the two controllers (P = 0.056, P = 0.102,
and P = 0.057, respectively); however, the difference in average positive and net bio-
logical ankle power were near significant. Subjects on average achieved ∼0.18 W kg-1
greater exoskeleton peak power when using the timing-based controller than when using
the proportional myoelectric controller (an increase of ∼11.1%). There was a statistically
significant difference between these peak power values (P = 0.048). This increase in peak
exoskeleton power corresponded with an average decrease in peak biological ankle power
of ∼0.11 W kg-1 when using the timing-based controller compared to the proportional my-
oelectric controller (a decrease of ∼8.3%). Due to large variability in subject data, this
observations was not of a statistically significant difference (P = 0.439).
Subjects put forth significantly greater positive average knee power when using the
proportional myoelectric controller than when using the timing-based controller (Fig. 5.7,
P = 0.003). There were no statistically significant differences in negative or net positive
power at the knee between the two controllers (P = 0.851 and P = 0.063, respectively).
Subjects showed large differences in average negative and net power at the hip between
powered and unpowered conditions. When using the the timing-based controller, subjects
had an average negative hip power 0.04± < 0.01 W kg-1 and an average net hip power
0.09 ± 0.02 W kg-1 larger than that when walking in the devices unpowered (an increase
of 52.3 ± 5.0% and 28.1 ± 4.1%, respectively). When using the proportional myoelectric
controller, subjects had an average negative hip power 0.05 ± 0.01 W kg-1 and an average
net hip power 0.09± 0.01 W kg-1 larger than that when walking in the devices unpowered
(an increase of 66.4 ± 9.8% and 28.0 ± 2.5%, respectively). There was no statistically
significant difference in average positive, negative, or net hip power between controllers
(P = 0.232, P = 0.057, and P = 0.934, respectively).
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5.4 Discussion
Our primary hypothesis was that metabolic work rate would differ between walking with
the timing-based mechanically intrinsic controller and the dynamic gain proportional my-
oelectric controller. However, we found quite the opposite. Results show that there was no
statistically significant difference in metabolic work rate between the two control strategies
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Figure 5.7: A breakdown of knee and hip power contributions from each walking condition.
(A) Mean knee power and mean hip power across the three walking conditions. (B) Average power
plots of positive, negative, and net power at the knee and hip. All error bars represent ± 1 s.e.m.
An asterisk above the plots represents a significant difference between the two powered walking
conditions (P < 0.05).
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in this experiment (Fig. 5.3). The reasoning for why we expected a different metabolic
work rate between controllers was that we expected subjects to use each controller in a
unique way due to the fact that one control strategy was dependent on muscle recruitment
and the other was not. Although we did not observe a difference in metabolic work rate,
we did observe differences in other biomechanical measures.
Soleus muscle recruitment differed between walking with the proportional myoelectric
controller and with the timing-based controller. Although there was not a statistically sig-
nificant difference in soleus r.m.s. EMG values between the two walking conditions, there
was a strong trend in subjects using less soleus muscle recruitment when using the timing-
based controller than when using the proportional myoelectric controller. This was made
evident by the absolute values of the r.m.s. EMG calculations and the fact that subjects’ re-
sulting soleus linear envelopes when using the timing-based controller were 11% less than
that of the proportional myoelectric controller during the mid and late stance phases of gait
(Fig. 5.4A). Additionally, the peak value of subjects’ soleus linear envelopes when using
the timing-based controller was significantly less than that when using the proportional
myoelectric controller. Similar trends were observed in medial gastrocnemius r.m.s. EMG
calculations as well.We believe the reason we did not observe differences in metabolic
work rate in this study despite this difference in muscle recruitment was that these devices
targeted a relatively small muscle group. If repeated with an exoskeleton that targeted
larger muscle groups, such as with a hip exoskeleton [5, 96, 120], it might be expected to
see differences in metabolic work rate; however, further research is needed to make this
conclusion.
The observed differences in recruitment of plantar flexor muscles had a direct effect
on resulting ankle mechanics. We observed that subjects walked with significantly larger
average positive and negative total ankle power when using the proportional myoelectric
controller than when using the timing-based controller (Fig. 5.6). This increase in power
magnitude at the ankle is due to the very slight differences in total ankle moment of the
two controller conditions (Fig. 5.5). In looking at the breakdown of total ankle power con-
tributions we see that subjects trended toward significantly larger peak exoskeleton power
output when using the timing-based controller than the proportional myoelectric controller
(an increase of 11.1%) . This corresponded with a trend in decreased peak biological ankle
power output (a decrease of 8.3%). Additionally, subjects used less average positive and net
biological ankle power when walking with the timing-based controller than with the pro-
portional myoelectric controller. These differences in average positive and net biological
ankle power were near statistical significance (P = 0.056 and P = 0.057, respectively).
These ankle power results suggest that when using the timing-based controller subjects
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were contributing less to locomotion at the biological ankle and are more so ‘along for the
ride’ [143]. This makes sense given that active engagement and involvement at the ankle
is not necessarily required when using the timing-based controller. So long as heel strike
occurs, subjects will receive actuation. When using the proportional myoelectric controller,
active involvement on a muscular level is necessary to directly control the actuation of the
device. Additionally, these changes in ankle dynamics seemed to have had an effect on
subjects average positive knee power as subjects walked with significantly more positive
knee power when using with the proportional myoelectric controller than when using with
the timing-based controller.
We attribute these differences in muscle recruitment, and thus the resulting observed
differences in ankle power, to the theory of slacking. The idea behind slacking is that the
human motor system is always trying to minimize its levels of muscle activation during
repetitive tasks where movement error is small, such as walking [113, 143]. One hypothe-
sis for interpreting the differences in soleus muscle recruitment between the two controllers
is that when using the proportional myoelectric controller, users can only slack so far be-
fore signal quality affects walking stability. This is an inherent technical limitation of using
measures of muscle activity to drive a controller. As mentioned prior, neural signals, such
as muscle activity, often have large noise content. Therefore as subjects decrease their
muscle activity, the signal-to-noise ratio of the measurement decreases making it difficult
to separate the signal from the noise. In this specific experiment, the dynamically adjusting
gain of the proportional myoelectric controller increases to compensate for decreases in
muscle activity. This larger gain will amplify any noise that makes it through the filter-
ing process along with the intended control signal. This amplified noise could then make
control of the device difficult and potentially cause for instability with walking. Given
this argument, we believe there is a maximum level of slacking that can be obtained with
the proportional myoelectric controller presented here. When using the timing-based con-
troller, the actuation is consistently the same for each step regardless of muscle activity.
Because of this, users can potentially slack their muscle activity further than with the pro-
portional myoelectric controller without any change to actuation.
Another hypothesis for interpreting the differences in soleus muscle recruitment be-
tween the two controllers is that when using the proportional myoelectric controller, users
can only slack so far due to the means in which the controller is triggered. No matter what,
subjects must use some amount of muscle recruitment to actuate the proportional myo-
electric controller. Due to the fact that this controller inherently guarantees synchronous
actuation with the user, the user is always moving with the device during actuation. When
using the timing-based controller, subjects do not necessarily need to move with the device.
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They could potentially lean into the actuation and let it propel them forward in a way that
is not possible with the proportional myoelectric controller. This could potentially explain
the observed increases in peak exoskeleton power and decreases in biological ankle power.
Once figuring out this strategy, subjects can exploit it and become disengaged at a muscle
level during walking. Thus, subjects are able to slack further when using the timing-based
controller.
Equally interesting to the resulting differences in these two control strategies are how in
which the two were similar. The results from this study show that regardless of the control
strategy being used, the actuation from the exoskeletons resulted in large reductions the
user’s metabolic work rate compared to walking unpowered in the devices. The absolute
value of these reductions is comparable to previous work in the field [77, 89, 101, 111].
Although it is not a novel finding to show that actuation of an exoskeleton can reduce the
metabolic work rate compared to unpowered walking, it is a good proof that both control
strategies were able to work in parallel with user to offload some of the energetic require-
ments of walking. Additionally, gait kinematics between the two controllers were relatively
unchanged (Tables 5.2 and 5.3). We found that all lower extremity joint kinematics were
largely unchanged from one controller to the other, as evident that all regressions between
the two controllers resulted in R2 values greater than 0.98 (Fig. 5.5). We also observed that
regardless of the controller being used, subjects adapted to large increases in total ankle
powered compared to the unpowered walking condition. This large increase in total ankle
power corresponded with large reductions in power at the hip. These reductions in hip
power were congruent with reductions in EMG activity at the rectus femoris (Fig. 5.4B).
This trade off in joint power and muscle activity between the ankle and hip is consistent
with previous work by our research group and that observed by others with different devices
and controllers [89,105,111]. We find all of these resulting similarities an interesting find-
ing as they shows that if designed properly, these two different types of control approaches
can result in very similar biomechanical and energetic adaptations. With the correct design,
a researcher could potentially use either type of control scheme with an ankle exoskeleton
and achieve largely the same results for steady-state walking; the major differences being
in the resulting ankle muscle recruitment and ankle mechanics.
It is difficult to pinpoint the reasons behind the biomechanical differences observed
between the two controllers, but the fact that they exist lend insight to when one controller
may be better suited than another. For example, if a device is targeted toward therapeutic
rehabilitation of neurological injuries [8], a controller driven by neural signals may be
more beneficial than one driven by mechanically intrinsic signals due to users being more
engaged at a muscle level when using a controller driven by neural signals. This suggestion
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is drawn from the success of gait training with human therapists being more successful than
that with robotic devices in patients with chronic stroke [70]. This difference is attributed
to patients’ active involvement when working with a therapist over a robotic device. As this
study has only considered testing with healthy subjects, further research would need to be
conducted with a clinical population to draw definitive conclusions on this. Additionally,
the results from this study suggest that if a metabolic reduction is of interest, it appears that
either type of control strategy could be employed.
We acknowledge that this study is a comparison of a single controller driven by neural
signals and a single controller driven by mechanically intrinsic signals. There are an infinite
number of possible controllers for each that could be compared; however, we believe this is
a strong starting point for future work in better understanding controller design for specific
applications. Seeing as each control strategy lends itself to different pros and cons, a hybrid
of the two approaches may be advantageous, an area of research many have already begun
exploring [6,94,129,148]. We also acknowledge that this experiment was performed with a
hardware platform that is constrained to a lab setting and is limited in torque output. Further
research would need to be performed to show how these principals hold on different devices
and walking scenarios.
5.5 Conclusion
This study aimed to compare the differences between walking in bilateral ankle exoskele-
tons using a dynamic gain proportional myoelectric controller and using a timing-based
mechanically intrinsic controller. We hypothesized that these two controllers would result
in different measures of metabolic work rate due to expected differences in biomechani-
cal measures. We observed no differences in metabolic work rate, small changes in joint
kinetics at the knee and hip, and virtually no difference on all leg joint kinematics be-
tween the two controllers. The major differences between these two controllers that we
did observe were at the ankle. Subjects showed increased soleus muscle activity when us-
ing the proportional myoelectric controller than when using the timing-based controller.
This corresponded with significantly larger positive and net total ankle power when using
the proportional myoelectric controller than when using the timing-based controller. These
findings suggest that a controller driven by neural signals may be better suited for therapeu-
tic rehabilitation applications while either controller is well suited for human augmentation
purposes.
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CHAPTER 6
Discussion and Conclusion
Through my dissertation work I have developed and explored the feasibility of adaptive
controllers for assistive robotic devices. Additionally, I have investigated the energetic and
biomechanical effects of such control schemes on the user, lending insight into how users
may adapt and use such devices. What is novel about these controllers is that they au-
tonomously adapt based upon a physiological measure taken from the user. To accomplish
this work, I first developed mathematical models and methods to analyze non-steady-state
physiological measures (Chapter 2). I then employed these mathematical techniques to
conduct the real-time optimization of an assistive robotic device through minimizing mea-
sures of users’ metabolic work rate (Chapter 3). Making a tangential step along the same
lines of adaptive control, I then showed how muscle recruitment could also be used as
a physiological measure to base adaptive control on (Chapter 4). Lastly, I conducted a
systematic comparison of the energetic and biomechanical outcomes between a controller
driven by neural signals versus a controller driven by mechanically intrinsic signals to in-
vestigate when one type of control may be more advantageous to use than another (Chapter
5). In this final chapter, I will discuss the implications of this work and how it can be built
upon in the future.
6.1 Discussion of Contributions
The field of assistive robotic devices faces the difficult question of how to best supply as-
sistance to a device’s user. A solution I have posed to this question is to allow the device
to adapt to the individual user. This technique allows for customized subject-specific con-
trol and lets an algorithm objectively answer the question of how to best supply assistance
to the user. The work I have described in the previous four chapters has targeted specific
areas of development that can allow for adaptive controllers to become clinically relevant
for assistive devices.
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The work I presented in Chapter 2 described a technique for estimating and analyzing
non-steady-state physiological measures. I took great care in developing this analysis such
that it can be applied generally to any physiological measure so long as the measure can be
described as a discrete linear system. In doing so, this work has laid the ground work for
future developments in using other physiological measures to drive adaptive controllers.
However, one of the major impacts of this work is its implications outside of the realm of
assistive robotic devices. The parameters considered when mapping a cost landscape do
not necessarily need to be parameters on an assistive robotic device. These parameters can
easily be any number of different movement parameters, such as walking speed, walking
inclines, or step frequency [63, 104, 133]. Therefore, these same techniques could be used
during general biomechanics experiments. Furthermore, the demonstrated experimental
application of the instantaneous cost mapping analysis in Chapter 2 showed that the de-
veloped techniques allow for the rapid exploration of a parameter space when analyzing
metabolic work rate. This has huge implications for clinical research as many patients with
disability cannot physically walk for the long durations of time required by the current
methods of steady-state analysis of metabolic work rate. By using the methods described
in this dissertation, experimental biomechanics work can be conducted with clinical popu-
lations without requiring them to walk for extended lengths of time. This opens the door to
a whole realm of biomechanics research that was not feasible prior to these methods being
developed.
The work I have described in Chapter 3 was the first ever example of optimizing the
control of an individual device based upon a user’s metabolic work rate. The techniques
developed in this chapter were also described as mathematically general as possible as to
be applicable to any dimensionality of space being optimized. This optimization approach
could drastically improve upon the current heuristic and subjective tuning of clinical de-
vices that is common practice in the prescription of a device as described in Chapter 1.
As such, a device could co-adapt with a user over long periods of time to identify optimal
parameter configurations all while the user learns to best use the device. Since publication,
a number of other research groups have built upon this technique using different control
paradigms and optimization algorithms [85, 152].
In Chapter 4, I presented an adaptive proportional myoelectric controller that adapted
to users’ levels of muscle recruitment. This research was unique in that it allowed for con-
trol driven by neural signals while always maximizing the devices power output regardless
of the levels of muscle recruitment the user adapted to. In doing so, this control scheme
allowed users to adapt to the amount of total ankle activity their body desired by regulat-
ing their own biological contribution all while the controller maintained synchronization
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between the device and the user. The results from this study showed that when given the
freedom to drive adaptation with their own muscle recruitment, subjects adapted toward in-
creases in total ankle power in order to decrease their levels of hip power and thus achieve
a reduction in their metabolic work rate compared to unpowered walking. This was the first
ever study with an assistive device to show this biomechanical interplay between the ankle
and hip. Since publication of this work, other studies have confirmed that this interplay is
evident despite different device hardware or control [105, 111]. This discovery can have
large implications in a clinical environment during device prescription. For example, if
someone has a disability that negatively affects the amount of hip power they can output
during gait, they may benefit from using an ankle exoskeleton. Additionally, the contribu-
tions of this work illustrate how healthy subjects adapt to added assistance at the ankle and
will aid in informing future device design.
Lastly, in Chapter 5 I investigated what some of the biomechanical and energetic dif-
ferences may be in using different controllers. Specifically, how would users use a device
differently if the controller were driven by neural signals versus driven by mechanically
intrinsic signals so long as each controller had the same average actuation signal. Find-
ings from this work show that energetically, the two controllers are equivalent for an ankle
exoskeleton meaning that if human augmentation is the application, either control strategy
could potentially be used. However, these same findings showed that subjects recruited less
muscle activity when using the controller driven by mechanically intrinsic measures. This
discovery suggests that a controller driven by neural signals may be better suited for appli-
cations in therapeutic rehabilitation as active involvement during motion has been shown
to have more positive outcomes than passive involvement [70]. The contributions of this
work may better inform device design for clinical applications focused on therapeutic re-
habilitation.
As a collection of work, the chapters of this dissertation have targeted the current state
of device tuning and evaluation and proposed a number of improvements that can have
a major impact on the field as a whole. Adaptive controllers for assistive devices is a
relatively new area of interest and research, but there is already quite a bit of momentum
surrounding it. The idea of Body-in-the-Loop optimization and adaptive tuning has already
been picked up by a number of other research groups in the field that are trying out different
algorithms on a wide variety of hardware [85,152]. However, to the best of my knowledge,
the studies presented here are the first examples of Body-in-the-Loop optimization and
adaptive tuning of a device based upon physiological measures. This ground work will be
a vital contribution to the field as it is the first known example of this concept being put to
use on a device, thus proving its feasibility.
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6.2 Limitations and Need for Future Research
Chapters 2 and 3 have focused on using metabolic work rate as the physiological objective
function to drive a Body-in-the-Loop optimization. Admittedly, metabolic work rate may
not be the only cost function to consider in such an optimization; however, it is a good start-
ing point for these types of adaptive controllers due to its ease of collection and ubiquity
in the field. During walking, there may be a large number of objective functions that the
human body cares about and these would need to be considered in such an optimization.
In order to propel this research forward, future research will need to consider additional
objective functions such as comfort, perceived effort, or stability; however, these metrics
are often difficult to quantify. Research aimed at targeting such objective functions through
alternative sensing means will be greatly beneficial to this area of work.
One limitation of focusing on driving an adaptive controller with measures of metabolic
work rate is that current methods for estimating metabolic work rate require using a mask
that covers the mouth to sample oxygen consumption and carbon dioxide production. It
is not feasible to be wearing such a mask on a daily basis when using a device. This
downfall makes adaptation based upon alternative physiological measures, such as muscle
activity as described in Chapter 4, much more appealing. Future research that focuses
on alternative and more discreet sensing of metabolic work rate will allow for adaptive
controllers to be more easily and readily implemented. Such work has already taken interest
in the field and their success could also allow for sensor fusion to consider multiple different
objective functions during an online optimization [12, 76]. In order to make Body-in-the-
Loop optimization obtainable to use in the real world, new sensing techniques will need to
be developed to allow for discrete and transparent sensing during daily use of the device.
The future real-world implementations of this research could be as simple as users putting
on a wearable sensing device, much like a Fitbit [128] or smart textile [135], to allow a
deceive to seamlessly adapt to the user throughout the day during use.
In addition to future work in sensing, work in algorithm development will also be cru-
cial to moving the implementation of adaptive controllers forward. The Body-in-the-Loop
optimization presented in Chapter 3 relied on a gradient descent algorithm. This simple al-
gorithm worked well in initial testing, but gradient descent methods have their draw backs.
Mainly, a gradient descent algorithm can get trapped in local minima. However, since a
gradient descent is only doing a local approximation of the cost landscape, it can easily
adapt to changing landscapes as is the case when a user is learning and adapting to a de-
vice. A gradient descent algorithm served as a good choice for proof of concept testing,
but this body of work could greatly benefit from further focus on more sophisticated al-
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gorithms. Future research will need to call upon non-convex optimization techniques or
machine learning to push this work forward.
6.3 Concluding Remarks
In my view, the two capstones of my dissertation work were the implementations of two
very different adaptive controllers as presented in Chapters 3 and 4. I took two very dif-
ferent approaches in designing these controllers and discussing their outcomes lends itself
to some very interesting observations. First, in the Body-in-the-Loop optimization work, I
designed a controller and algorithm that was explicitly told to adapt such that it minimized
users’ energetic consumption. In this framework, I as the designer have predefined a target
outcome of the human-machine system. Inherently, I have encoded and decided that the
exoskeleton and wearer will work together in a way that minimizes the measured metabolic
work rate. In contrast to that, with the adaptive gain proportional myoelectric controller I
have designed a controller that was only told to maintain maximal power output regardless
of the users muscle recruitment. This controller design can be thought of as an adaptive
controller that is adapting in order to maintain a constant output. In this framework, I as
the designer have only predefined a target outcome for the machine of the human-machine
system. In doing so, I have allowed the human nervous system to adapt and use the de-
vice in whatever way it preferred. With this difference in predefined outcomes of the two
controllers in mind, we can make some interesting observations.
In the case of the adaptive myoelectic controller, the human system is treated as some-
what of a black box. Because in this study the human system is truly driving the adaptation
of the device, albeit unconsciously, how the device is being used is completely unknown
to the controller. Unlike the Body-in-the-Loop optimization, the adaptive myoelectic con-
troller has no notion of a cost landscape or a target physiological measure to minimize.
However, the human nervous system seems to. When adapting and using this type of con-
troller, the human nervous system is theoretically conducting its own optimization based
upon some cost landscape that is unknown to us. It is difficult to determine what the objec-
tive function is that the human nervous system is trying to minimize as it adapts to the added
assistance of the device; nonetheless, it would appear that energetic cost is a large part of
it. Subjects adapted their gait over multiple training sessions to lower their metabolic work
rate. Most interestingly, subjects adapted to using unconventional joint mechanics in doing
so as they increased their levels of total ankle power and reduced their levels of hip power
compared to unpowered walking. This was an outcome that was only made possible due to
the added power the device.
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I am by no means advocating for one type of adaptive controller over another, but I
think it is important to identify the differences in each. The Body-in-the-Loop approach is
dependent upon some definition of a target outcome by the designer. In my work I have
focused on metabolic work rate, but you could imagine how the objective function of this
optimization could easily be altered to something different such as muscle activity, joint
mechanics, or gait symmetry. What is interesting about this a priori definition of outcome
is that the designer needs to have some expectation for what the human system will do.
Where this becomes difficult is it is not always obvious how the human body will adapt to
a given device. Take for example the unexpected biomechanical outcomes of the testing
with the adaptive myoelectric controller. Given these results, I believe it is unclear if we
as designers should be the ones guessing about how the human system will or should use
a given device until we have a better understanding of what the human nervous system is
adapting for. As our understandings of how the human system adapts to added assistance
becomes more clear, we can begin to make larger strides in the adaptive control of assistive
robotic devices.
The work I have focused on during my dissertation is among the pioneering research
in the realm of adaptive control for assistive robotic devices. As such, this work has set
the path for an infinite number of subsequent research questions that incorporates con-
trol, human-machine interactions, physiological modeling, and human biomechanics. This
work has paved the way for many years of interesting and clinically relevant research ques-
tions to come. Most importantly, this work has proven that adaptive controllers driven by
physiological measures is even feasible. There is no doubt in my mind that adaptive con-
trollers will be the standard for future assistive robotic devices and this is a vital area in
which our field will begin to focus its efforts.
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